Processing 00000000.tx.1: Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer A42 Peptide Relative to A40* Woojin Kim and Michael H. 

Phrase: "Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer A42 Peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C3244091:determinant peptide [Idea or Concept]
   708   C1521761:Determinant [Functional Concept]

Phrase: "Relative to A40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "* Woojin Kim"

Phrase: "and"

Phrase: "Michael H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: Hecht1 From the Department of Chemistry, Princeton University, Princeton, New Jersey 08544 Received for publication, May 26, 2005 , and in revised form, August 2, 2005.  

Phrase: "Hecht1 From the Department of Chemistry,"

Phrase: "Princeton University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0331889:Princeton [Health Care Related Organization]

Phrase: "Princeton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331889:Princeton [Health Care Related Organization]

Phrase: "New Jersey 08544"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027971:New Jersey [Geographic Area]
   827   C0205314:New [Temporal Concept]
   827   C0454673:Jersey [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "May 26,"

Phrase: "2005 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "August 2,"

Phrase: "2005."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Aggregation of proteins into insoluble deposits is associated with a variety of human diseases. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Aggregation of proteins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "into insoluble deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "is"

Phrase: "associated with a variety of human diseases."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   757   C0243083:associated disease [Pathologic Function]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0086418:Human [Human]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.4: In Alzheimer disease, the aggregation of amyloid (A) peptides is believed to play a key role in pathogenesis. 

Phrase: "In Alzheimer disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the aggregation of amyloid (A) peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a key role in pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.5: Although the 40-mer (A40) is produced in vivo at higher levels than the 42-mer (A42), senile plaque in diseased brains is composed primarily of A42. 

Phrase: "Although"

Phrase: "the 40-mer (A40"

Phrase: ")"

Phrase: "is"

Phrase: "produced"

Phrase: "in vivo at higher levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "than the 42-mer (A42"

Phrase: ")"

Phrase: ","

Phrase: "senile plaque in diseased brains"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0333463:Senile plaque [Acquired Abnormality]
           plaque
   760   C0011389:Plaque [Disease or Syndrome]
   760   C0332461:Plaque [Finding]
   760   C0392079:Senile [Finding]
   704 E C0231337:Old age [Finding]
   704 E C1999167:Old age [Population Group]

Phrase: "is"

Phrase: "composed"

Phrase: "primarily of A42."
Processing 00000000.tx.6: Likewise, in vitro, A42 forms fibrils more rapidly than A40. 

Phrase: "Likewise,"

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "A42"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "fibrils more rapidly than A40."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0225328:fibrils [Cell Component]
   760   C1637379:Rapidly [Qualitative Concept]
   726 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.7: The enhanced amyloidogenicity of A42 could be due simply to its greater length. 

Phrase: "The enhanced amyloidogenicity of A42"

Phrase: "could"

Phrase: "be"

Phrase: "due simply to its greater length."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0678226:Due to [Functional Concept]
           due
   753   C0443228:greater [Quantitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   753   C3146286:Due [Idea or Concept]
   719 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.8: Alternatively, specific properties of residues Ile41 and Ala42 might favor aggregation. 

Phrase: "Alternatively,"

Phrase: "specific properties of residues Ile41"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "Ala42"

Phrase: "might"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.9: To distinguish between these two possibilities, we constructed a library of sequences in which residues 41 and 42 were randomized. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish between these two possibilities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "a library of sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023621:Library [Manufactured Object,Organization]
   770   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in which residues 41"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "42"

Phrase: "were"

Phrase: "randomized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034656:randomized [Research Activity]
Processing 00000000.tx.10: The aggregation behavior of the resulting sequences was assessed using a high throughput screen, based on the finding that fusions of A42 to green fluorescence protein (GFP) prevent the folding and fluorescence of GFP, whereas mutations in A42 that disrupt aggregation produce green fluorescent fusions. 

Phrase: "The aggregation behavior of the resulting sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0004927:Behavior [Individual Behavior]
   748   C2707008:Behavior [Clinical Attribute]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a high throughput screen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220908:screen [Health Care Activity]
   827   C1305399:screen [Functional Concept]
   827   C1705053:Screen [Medical Device]

Phrase: "based on the finding"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2825141:Finding [Finding]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that fusions of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332466:fusions [Functional Concept]
   770   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "to green fluorescence protein (GFP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   976   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the folding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "fluorescence of GFP,"

Phrase: "whereas"

Phrase: "mutations in A42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "produce"

Phrase: "green fluorescent fusions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332466:fusions [Functional Concept]
   827   C1293131:fusions [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: Correlations between the sequences of A42 mutants and the fluorescence of A42-GFP fusions in vivo were confirmed in vitro through biophysical studies of synthetic 42-residue peptides. 

Phrase: "Correlations between the sequences of A42 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the fluorescence of A42-GFP fusions"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "were"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "in vitro through biophysical studies of synthetic 42-residue peptides."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   761   C0681828:in vitro study [Research Activity]
           studies vitro
   760   C0021135:In Vitro [Intellectual Product]
   760   C1533691:in vitro [Qualitative Concept]
           vitro
   760   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.12: The data reveal a strong correlation between aggregation propensity and the hydrophobicity and -sheet propensities of residues at positions 41 and 42. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a strong correlation between aggregation propensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the hydrophobicity"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobicity [Qualitative Concept]
   907 E C0034494:Rabies [Disease or Syndrome]
   907 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   900 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "and -"

Phrase: "sheet propensities of residues"

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42."
Processing 00000000.tx.13: Moreover, several mutants containing hydrophilic residues and/or -sheet breakers at positions 41 and/or 42 were less prone to aggregate than A40 wherein these two residues are deleted entirely. 

Phrase: "Moreover,"

Phrase: "several mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "hydrophilic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and/or -"

Phrase: "sheet breakers at positions 41"

Phrase: "and/or"

Phrase: "42"

Phrase: "were"

Phrase: "less prone to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033422:Prone [Spatial Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "aggregate than A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205418:Aggregate [Qualitative Concept]

Phrase: "wherein"

Phrase: "these two residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "entirely."
Processing 00000000.tx.14: Thus, properties of the side chains at positions 41 and 42, rather than length per se, cause A42 to aggregate more readily than A40.  

Phrase: "Thus,"

Phrase: "properties of the side chains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42,"

Phrase: "rather than"

Phrase: "length per se, cause A42 to"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "more readily than A40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205172:More [Functional Concept]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The deposition of insoluble proteins into amyloid plaque is associated with various diseases including Alzheimer disease, prion encephalopathies, Parkinson disease, and Huntington disease (1-4). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The deposition of insoluble proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0333584:Protein deposition [Pathologic Function]
   760   C0333562:Deposition [Functional Concept]

Phrase: "into amyloid plaque"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
  1000   C2936349:Plaque, Amyloid [Acquired Abnormality]
   861   C0011389:Plaque [Disease or Syndrome]
   861   C0332461:Plaque [Finding]

Phrase: "is"

Phrase: "associated with various diseases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   802   C0243083:associated disease [Pathologic Function]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimer disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "prion encephalopathies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085584:Encephalopathies [Disease or Syndrome]
   827 E C1963101:Encephalopathy [Finding]

Phrase: "Parkinson disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "Huntington disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: In Alzheimer disease, amyloid (A)2 peptides aggregate into fibrils, which accumulate as insoluble neuritic plaques. 

Phrase: "In Alzheimer disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: "2 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "aggregate into fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205418:Aggregate [Qualitative Concept]
   790   C0225328:fibrils [Cell Component]
   756 E C1948066:Fibril [Physical Object]

Phrase: "which"

Phrase: "accumulate as insoluble neuritic plaques."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
Processing 00000000.tx.17: A variety of genetic, neuropathological, and biochemical studies suggests that either the fibrils themselves or precursors on the pathway toward these fibrils play a causative role in Alzheimer disease (1, 5-11). 

Phrase: "A variety of genetic, neuropathological,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "biochemical studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205474:Biochemical [Functional Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that either"

Phrase: "the fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "themselves"

Phrase: "or"

Phrase: "precursors on the pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709634:Precursor [Idea or Concept]

Phrase: "toward these fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a causative role in Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5-11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.18: A peptides are produced in vivo by proteolytic cleavage of the amyloid precursor protein by and secretases (5). 

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "produced"

Phrase: "in vivo by proteolytic cleavage of the amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "by"

Phrase: "and"

Phrase: "secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.19: Because of inhomogeneous cleavage by secretase, A peptides range in length from 39 to 43 residues. 

Phrase: "Because of inhomogeneous cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "by secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "A peptides range in length"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "from 39"

Phrase: "to 43 residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.20: Among these peptides, the 40-mer (A40) and the 42-mer (A42) are abundant in diseased brains (12-14), and these two peptides are the main components of the neuritic plaques in the parenchyma of diseased brains (5, 14). 

Phrase: "Among these peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "the 40-mer (A40"

Phrase: ")"

Phrase: "and"

Phrase: "the 42-mer (A42"

Phrase: ")"

Phrase: "are"

Phrase: "abundant in diseased brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "(12-14"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "these two peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "the main components of the neuritic plaques"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "in the parenchyma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "of diseased brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.21: With the exception of the C-terminal amino acids, Ile41 and Ala42, the sequences of A40 and A42 are identical. 

Phrase: "With the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of the C-terminal amino acids,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "Ile41"

Phrase: "and"

Phrase: "Ala42,"

Phrase: "the sequences of A40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "A42"

Phrase: "are"

Phrase: "identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.22: Despite their 95% sequence identity, A40 and A42 display dramatically different behaviors both in vivo and in vitro. 

Phrase: "Despite their 95% sequence identity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0424215:Identity [Mental Process]
   827   C2003939:Identity [Finding]

Phrase: "A40"

Phrase: "and"

Phrase: "A42"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "dramatically different behaviors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0004927:Behaviors [Individual Behavior]
   827   C0677505:behaviors [Finding]
   793 E C2707008:Behavior [Clinical Attribute]
   743 E C2986890:Behavioral [Idea or Concept]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.23: Biochemical and immunocytochemical studies show that although A40 is major component in cerebrospinal fluid and plasma, senile amyloid plaques formed in vivo are composed primarily of A42 (5, 14-16). 

Phrase: "Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "immunocytochemical studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "although"

Phrase: "A40"

Phrase: "is"

Phrase: "major component in cerebrospinal fluid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "plasma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "senile amyloid plaques"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C0333463:Senile Plaques [Acquired Abnormality]
           amyloid plaques
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "are"

Phrase: "composed"

Phrase: "primarily of A42"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "14-16"

Phrase: ")."
Processing 00000000.tx.24: Moreover, although both peptides aggregate into fibrils in vitro, A42 does so more rapidly than A40. 

Phrase: "Moreover,"

Phrase: "although"

Phrase: "both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "aggregate into fibrils in vitro, A42"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0205418:Aggregate [Qualitative Concept]
   753   C0225328:fibrils [Cell Component]
   719 E C1948066:Fibril [Physical Object]

Phrase: "does"

Phrase: "so more rapidly than A40."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037640:SO [Geographic Area]
   760   C1637379:Rapidly [Qualitative Concept]
Processing 00000000.tx.25: Concentrated solutions of A40 are stable for days, whereas comparable solutions of A42 aggregate almost immediately (17, 18). 

Phrase: "Concentrated solutions of A40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   816   C1707468:Concentrated Solution [Biomedical or Dental Material]
   770   C0037633:Solutions [Substance]
   737 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "are"

Phrase: "stable for days,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205360:Stable [Qualitative Concept]
   790   C1547311:Stable [Intellectual Product]

Phrase: "whereas"

Phrase: "comparable solutions of A42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0037633:Solutions [Substance]
   737 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "almost immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205548:Immediately [Temporal Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.26: Not only is A42 more prone to aggregate than A40, but the pathways toward aggregation are also different. 

Phrase: "Not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "is"

Phrase: "A42 more prone to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033422:Prone [Spatial Concept]

Phrase: "aggregate than A40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205418:Aggregate [Qualitative Concept]

Phrase: "but"

Phrase: "the pathways toward aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "also different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.27: Recently, Teplow and coworkers (19, 20) found that carefully prepared aggregate-free A40 occurs as monomers, dimers, trimers, and tetramers in rapid equilibrium. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Teplow"

Phrase: "and"

Phrase: "coworkers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681088:coworkers [Population Group]

Phrase: "(19,"

Phrase: "20"

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that carefully prepared aggregate-free A40"

Phrase: "occurs as monomers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596973:monomers [Chemical Viewed Structurally]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "trimers,"

Phrase: "and"

Phrase: "tetramers in rapid equilibrium."
Processing 00000000.tx.28: In contrast, A42 preferentially forms pentamer/hexamer units (paranuclei) that assembled further into beaded superstructures similar to early protofibrils. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "A42 preferentially"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "pentamer/hexamer units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "(paranuclei"

Phrase: ")"

Phrase: "that assembled further into beaded superstructures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1517331:Further [Spatial Concept]
   719 E C0205108:far [Spatial Concept]

Phrase: "similar to early protofibrils."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.29: The different aggregation behaviors of A40 and A42 led us to question the role of the two C-terminal residues, Ile41 and Ala42. 

Phrase: "The different aggregation behaviors of A40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0004927:Behaviors [Individual Behavior]
   753   C0677505:behaviors [Finding]
   719 E C2707008:Behavior [Clinical Attribute]

Phrase: "and"

Phrase: "A42"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "the role of the two C-terminal residues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "Ile41"

Phrase: "and"

Phrase: "Ala42."
Processing 00000000.tx.30: Is it simply the increased length of A42 that causes its increased amyloidogenicity? 

Phrase: "Is"

Phrase: "it simply"

Phrase: "the increased length of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "that"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "its increased amyloidogenicity?"
Processing 00000000.tx.31: Or are particular features of the Ile41 and Ala42 side chains important for amyloid formation? 

Phrase: "Or"

Phrase: "are"

Phrase: "particular features of the Ile41"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "Ala42 side chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0337112:chains [Manufactured Object]
   827   C0441987:Side [Spatial Concept]
   827   C1524075:Chains [Idea or Concept]

Phrase: "important for amyloid formation?"
Processing 00000000.tx.32: To address these questions, we performed random mutagenesis on positions 41 and 42. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "these questions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "random mutagenesis on positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079866:Mutagenesis [Molecular Function]
   760   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "and"

Phrase: "42."
Processing 00000000.tx.33: The change in aggregation behavior resulting from the mutations was monitored by using fusions of the A42 variants to GFP. 

Phrase: "The change in aggregation behavior"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0542299:Change in behavior [Individual Behavior]
           behavior change
   806   C0025320:The change [Physiologic Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "resulting from the mutations"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0026882:Mutations [Genetic Function]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]
   737 E C2825142:Result [Finding]

Phrase: "was"

Phrase: "monitored by"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0030695:monitor [Health Care Activity]
   799   C0150369:monitor [Health Care Activity]
   799   C0181904:Monitor [Medical Device]
   799   C0596972:Monitor [Medical Device]
   799   C1521743:Monitor [Professional or Occupational Group]
   799   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fusions of the A42 variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332466:fusions [Functional Concept]
   760   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "to GFP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   976   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.34: Fluorescence of these fusions is inversely correlated with the propensity of the fused A mutant sequence to aggregate (21); 

Phrase: "Fluorescence of these fusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "inversely"

Phrase: "correlated with the propensity of the fused A mutant"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0699952:Fused [Functional Concept]
   742   C1707520:Correlated [Qualitative Concept]
   708 E C1414861:FUSE [Gene or Genome]
   708 E C1708111:Fuse [Manufactured Object]

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.35: GFP fused to wild type A42 does not fluorescence, whereas fusions to less aggregating mutants display increased fluorescence. 

Phrase: "GFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   976   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fused to wild type A42"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C0699952:Fused [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C1414861:FUSE [Gene or Genome]
   726 E C1708111:Fuse [Manufactured Object]

Phrase: "does"

Phrase: "not fluorescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "whereas"

Phrase: "fusions to less aggregating mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332466:fusions [Functional Concept]
   760   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "increased fluorescence."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.36: By correlating the observed levels of fluorescence with the identities of the side chains at positions 41 and 42, we determined the side chain properties at these positions that are responsible for the enhanced aggregation of A42 relative to A40.  

Phrase: "By correlating"

Phrase: "the observed levels of fluorescence"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "with the identities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0424215:identities [Mental Process]
   966 E C2003939:Identity [Finding]

Phrase: "of the side chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337112:chains [Manufactured Object]
   861   C0441987:Side [Spatial Concept]
   861   C1524075:Chains [Idea or Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42,"

Phrase: "we"

Phrase: "determined"

Phrase: "the side chain properties at these positions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "that"

Phrase: "are"

Phrase: "responsible for the enhanced aggregation of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "relative to A40."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.37: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Construction of Libraries of A42-GFP FusionsOligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA), and restriction enzymes were purchased from New England Biolabs. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Construction of Libraries of A42-GFP FusionsOligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "purchased from Integrated DNA Technologies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1158478:DNA Integration [Genetic Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0039421:technologies [Occupation or Discipline]
   760   C0869011:purchased [Activity]

Phrase: "(Coralville,"

Phrase: "IA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947960:Ia [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "restriction enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
   861   C0443288:Restriction [Functional Concept]

Phrase: "were"

Phrase: "purchased from New England Biolabs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027965:New England [Geographic Area]
   760   C0014282:England [Geographic Area]
   760   C0205314:New [Temporal Concept]
   760   C0869011:purchased [Activity]
Processing 00000000.tx.38: Mutations were incorporated into a synthetic A42 gene (21) by PCR using DeepVent polymerase (New England Biolabs) and an Ericomp EasycyclerTM Twinblock thermocycler. 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "incorporated into a synthetic A42 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0017374:Synthetic Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C1883254:synthetic [Activity]

Phrase: "(21"

Phrase: ")"

Phrase: "by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DeepVent polymerase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "an Ericomp EasycyclerTM Twinblock thermocycler."
Processing 00000000.tx.39: After PCR, the mutagenized A42 gene inserts and the pET 28 vector containing the GFP gene (21) were doubly digested with BamHI and NdeI. 

Phrase: "After PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "the mutagenized A42 gene inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0813036:Inserts [Medical Device]
   779 E C0441587:Insert [Health Care Activity]
   779 E C1743766:Insert [Medical Device]
   779 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "the pET 28 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the GFP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   733   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(21"

Phrase: ")"

Phrase: "were"

Phrase: "doubly"

Phrase: "digested with BamHI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "NdeI."
Processing 00000000.tx.40: The digested insert and vector were then ligated together using T4 ligase. 

Phrase: "The digested insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441587:Insert [Health Care Activity]
   861   C1743766:Insert [Medical Device]
   861   C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "ligated"

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "T4 ligase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.41: Plasmids were transformed into the XL1-Blue strain of Escherichia coli (Stratagene) and plated for overnight growth on plates containing 50 g/ml kanamycin. 

Phrase: "Plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "transformed into the XL1-Blue strain of Escherichia coli"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0014834:Escherichia coli [Bacterium]
   742   C0014833:Escherichia [Bacterium]
   742   C0080194:Strain [Injury or Poisoning]
   742   C0456178:strain [Intellectual Product]
   742   C1260957:Blue [Qualitative Concept]
   742   C1510411:Transformed [Pathologic Function]
   742   C1518614:Strain [Organism]
   742   C2987481:Strain [Mental Process]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "and"

Phrase: "plated for overnight growth"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   802   C0014570:Growth Plate [Body Part, Organ, or Organ Component]
   802   C0018283:Growth Plate [Tissue]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C0439583:Overnight [Temporal Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "on plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 g/ml kanamycin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0022487:Kanamycin [Antibiotic,Carbohydrate]
   756 E C0022491:Kantrex [Antibiotic,Carbohydrate]
Processing 00000000.tx.42: The primer for random mutagenesis at position 41 and 42 had the following sequence: 5'-TCTTCTGGATCCNNNNNNCACCACGCCGCCCACCAT-3'. 

Phrase: "The primer for random mutagenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at position 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42"

Phrase: "had"

Phrase: "the following sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: ":"

Phrase: "5'-TCTTCTGGATCCNNNNNNCACCACGCCGCCCACCAT-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.43: The primer for mutagenesis encoding a combinatorial mix of polar residues used the degenerate codon NAN. 

Phrase: "The primer for mutagenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a combinatorial mix of polar residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205430:Mix [Functional Concept]
   753   C1421951:MIX [Gene or Genome]
   753   C1720722:Mix [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the degenerate codon NAN."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1140111:nan [Intellectual Product]
   827   C1419854:NaN [Gene or Genome]
Processing 00000000.tx.44: For a combinatorial mix of hydrophobic residues we used the degenerate codon NTN (where N denotes a mixture of A, G, C, and T). 

Phrase: "For a combinatorial mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205430:Mix [Functional Concept]
   861   C1421951:MIX [Gene or Genome]
   861   C1720722:Mix [Qualitative Concept]

Phrase: "of hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the degenerate codon NTN"

Phrase: "(where N"

Phrase: "denotes"

Phrase: "a mixture of A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "C,"

Phrase: "and"

Phrase: "T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.45: Screening of Green/White PhenotypeDNA libraries were isolated from E. coli strain XL1-Blue, transformed into BL21(DE3) (23), and plated onto nitrocellulose paper (Millipore NC-HATF 83 mm) on LB plates containing 50 g/ml kanamycin. 

Phrase: "Screening of Green/White PhenotypeDNA libraries"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0220908:Screening [Health Care Activity]
   753   C0220909:screening [Functional Concept]
   753   C1698960:screening [Intellectual Product]
   753   C1710031:Screening [Diagnostic Procedure]
   753   C1710477:SCREENING [Research Activity]

Phrase: "were"

Phrase: "isolated from E. coli strain XL1-Blue,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0014834:E coli [Bacterium]
   748   C0080194:Strain [Injury or Poisoning]
   748   C0205409:Isolated [Functional Concept]
   748   C0456178:strain [Intellectual Product]
   748   C1260957:Blue [Qualitative Concept]
   748   C1518614:Strain [Organism]
   748   C1548221:Isolated [Idea or Concept]
   748   C2987481:Strain [Mental Process]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "transformed into BL21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450615:BL21 [Body Location or Region]
   790   C1510411:Transformed [Pathologic Function]

Phrase: "(DE3"

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "plated onto nitrocellulose paper"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030351:Paper [Manufactured Object]
   770   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C1547566:Paper [Idea or Concept]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "(Millipore NC-HATF 83 mm) on LB plates"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 g/ml kanamycin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0022487:Kanamycin [Antibiotic,Carbohydrate]
   756 E C0022491:Kantrex [Antibiotic,Carbohydrate]
Processing 00000000.tx.46: Following overnight growth at 37 C, the nitrocellulose papers were transferred to LB plates containing 50 g/ml kanamycin and 1 mM isopropyl 1-thio--D-galactopyranoside and incubated at 30 C for 4 h to induce the expression of the A-GFP fusion protein. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "overnight growth at 37 C,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "the nitrocellulose papers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0030351:Papers [Manufactured Object]
   827 E C1547566:Paper [Idea or Concept]

Phrase: "were"

Phrase: "transferred to LB plates"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0348011:transferred [Functional Concept]
   770   C1139930:plates [Medical Device]
   737 E C0005971:Plate [Medical Device]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 g/ml kanamycin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0022487:Kanamycin [Antibiotic,Carbohydrate]
   756 E C0022491:Kantrex [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "1 mM isopropyl 1-thio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1412102:THIO [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "incubated at 30 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 4 h to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of the A-GFP fusion protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C1517332:Fusion Protein Expression [Cell or Molecular Dysfunction]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.47: Colonies were counted and the green/white phenotype was recorded (21). 

Phrase: "Colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439158:colonies [Quantitative Concept]
   966 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "the green/white phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "was"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.48: Fluorescence MeasurementsTo enable measurement of the fluorescence of the A42-GFP fusions in vivo, colonies were picked, and cultures were grown in LB liquid media containing 50 g/ml kanamycin. 

Phrase: "Fluorescence MeasurementsTo"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "measurement of the fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "of the A42-GFP fusions in vivo, colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0439158:colonies [Quantitative Concept]
   760 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "picked"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1707391:Picked [Activity]
   966 E C1826583:PICK [Gene or Genome]

Phrase: ","

Phrase: "and"

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "grown in LB liquid media"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0302908:Liquid [Substance]
   760   C1254021:Media [Tissue]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 g/ml kanamycin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0022487:Kanamycin [Antibiotic,Carbohydrate]
   756 E C0022491:Kantrex [Antibiotic,Carbohydrate]
Processing 00000000.tx.49: When cultures reached an absorbance at 600 nm of 0.8, expression was induced by addition of isopropyl 1-thio--D-galactopyranoside to a concentration of 1 mM, and growth was continued for an additional 5 h 30 min at 30 C. 

Phrase: "When"

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "an absorbance at 600 nm of 0.8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1268822:Absorbance [Clinical Attribute]
   744   C2825050:Absorbance [Phenomenon or Process]

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "induced by addition of isopropyl 1-thio"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205263:Induced [Functional Concept]
   748   C1412102:THIO [Gene or Genome]
   748   C1883712:Addition [Functional Concept]
   748   C2945717:isopropyl [Chemical Viewed Structurally]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside to a concentration of 1 mM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "was"

Phrase: "continued for an additional 5 h 30 min"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0456693:/30 min [Temporal Concept]
   770   C1442458:30 min [Temporal Concept]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0549178:Continued [Idea or Concept]
   744   C0564385:/h [Quantitative Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1524062:Additional [Functional Concept]

Phrase: "at 30 C."
Processing 00000000.tx.50: After induction, cultures were diluted in Tris-buffered saline to an A600 nm of 0.15. 

Phrase: "After induction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "diluted in Tris-buffered saline"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "to an A600 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "of 0.15."
Processing 00000000.tx.51: Fluorescence was measured using a 50B spectrofluorimeter (PerkinElmer Life Sciences) with excitation at 490 nm and emission at 510 nm. 

Phrase: "Fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 50B spectrofluorimeter"

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "with excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "at 490 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "emission at 510 nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233929:Emission [Body Substance]
   770   C2349995:Emission [Substance]
Processing 00000000.tx.52: Expression of A42-GFP fusions was assessed by removing 200 l of cell culture and analyzing the whole cell content by SDS-PAGE. 

Phrase: "Expression of A42-GFP fusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C1517332:Fusion Protein Expression [Cell or Molecular Dysfunction]
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assessed by removing 200 l of cell culture"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0007585:Cell Culture [Laboratory Procedure]
   767   C0022827:cell l [Cell]
   744   C0007634:Cell [Cell]
   744   C0010453:Culture [Idea or Concept]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C1269647:Cell [Cell]
   744   C1516048:Assessed [Activity]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2242979:Culture [Laboratory Procedure]
   711   C0849355:remove [Qualitative Concept]
   711   C1883720:Remove [Activity]
   711   C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "analyzing"

Phrase: "the whole cell content by SDS-PAGE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.53: Correlation of Fluorescence with Biophysical PropertiesThe fluorescence of the A42-GFP fusions in vivo was plotted against the sum of hydrophobicities or against the sum of the -sheet propensities at positions 41 and 42. 

Phrase: "Correlation of Fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlation [Qualitative Concept]

Phrase: "with Biophysical PropertiesThe fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "of the A42-GFP fusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332466:fusions [Functional Concept]
   804   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "was"

Phrase: "plotted against the sum of hydrophobicities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0598629:Hydrophobicities [Qualitative Concept]
   753   C1515051:Sum [Quantitative Concept]

Phrase: "or against the sum of the -sheet propensities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1515051:Sum [Quantitative Concept]
   744   C2349187:Sheet [Quantitative Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42."
Processing 00000000.tx.54: Hydrophobicities were based on the scale of Kyte and Doolittle (24), and -sheet propensities were based on the scale of Minor and Kim (25). 

Phrase: "Hydrophobicities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobicities [Qualitative Concept]
   900 E C0034494:Rabies [Disease or Syndrome]
   900 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   893 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "were"

Phrase: "based on the scale of Kyte"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0175659:Scale [Medical Device]
   753   C0349674:Scale [Intellectual Product]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1947916:Scale [Activity]
   753   C3536777:Scale [Manufactured Object]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "Doolittle"

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "sheet propensities"

Phrase: "were"

Phrase: "based on the scale of Minor"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0026193:Minor [Population Group]
   753   C0175659:Scale [Medical Device]
   753   C0205165:Minor [Qualitative Concept]
   753   C0349674:Scale [Intellectual Product]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1947916:Scale [Activity]
   753   C3536777:Scale [Manufactured Object]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "Kim"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.55: In a further analysis, fluorescence was plotted against the predicted aggregation rates using Equation 1 as developed by Chiti et al. 

Phrase: "In a further analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "plotted against the predicted aggregation rates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
   753   C0681842:Predicted [Idea or Concept]
   753   C1882327:%{Predicted} [Quantitative Concept]
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Equation 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]

Phrase: "as"

Phrase: "developed by Chiti et al."
Processing 00000000.tx.56: (26). 

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.57: (Eq.1) In Equation 1, mut and wt are the aggregation rates of the mutant and wild type sequences, respectively; 

Phrase: "(Eq.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:EQ [Qualitative Concept]
   861   C0439185:Eq [Quantitative Concept]

Phrase: ")"

Phrase: "In Equation 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]

Phrase: "mut"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417504:MUT [Gene or Genome]

Phrase: "and"

Phrase: "wt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "are"

Phrase: "the aggregation rates of the mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "wild type sequences,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.58: Hydr is the difference in hydrophobicity, and (Gcoil- +G-coil) is the difference in the propensity to convert from -helix to -sheet. 

Phrase: "Hydr"

Phrase: "is"

Phrase: "the difference in hydrophobicity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and ("

Phrase: "Gcoil- +G-coil"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0444764:coil [Spatial Concept]
   827   C1413568:COIL [Gene or Genome]
   827   C1705946:Coil [Medical Device]

Phrase: ")"

Phrase: "is"

Phrase: "the difference in the propensity to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "convert from -helix to -sheet."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018882:Helix [Eukaryote]
   760   C0229304:Helix [Body Part, Organ, or Organ Component]
   760   C1704821:Helix [Spatial Concept]
   760   C1705682:Helix [Anatomical Structure]
   760   C2349187:Sheet [Quantitative Concept]
Processing 00000000.tx.59: (Note, the two s are added rather than subtracted. This is because subtraction is already accomplished by the definition of the terms. In the first term is subtracted from coil, and in the second term coil is subtracted from .) Charge is the difference in charge, and A, B, and C are empirically determined constants. 

Phrase: "(Note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the two s"

Phrase: "are"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "rather than"

Phrase: "subtracted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719767:Subtract [Intellectual Product]
   966   C2348589:Subtract [Phenomenon or Process]

Phrase: "This"

Phrase: "is"

Phrase: "because"

Phrase: "subtraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348589:Subtraction [Phenomenon or Process]

Phrase: "is"

Phrase: "already"

Phrase: "accomplished by the definition of the terms."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C1550452:definition [Idea or Concept]
   748   C1704788:Definition [Conceptual Entity]
   748   C3539107:Definition [Intellectual Product]
   714   C1515273:Term [Temporal Concept]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "In the first term"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "is"

Phrase: "subtracted from coil,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0444764:coil [Spatial Concept]
   790   C1413568:COIL [Gene or Genome]
   790   C1705946:Coil [Medical Device]
   756   C1719767:Subtract [Intellectual Product]
   756   C2348589:Subtract [Phenomenon or Process]

Phrase: "and in the second term coil"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0205436:Second [Quantitative Concept]
   753   C0444764:coil [Spatial Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C1413568:COIL [Gene or Genome]
   753   C1515273:Term [Temporal Concept]
   753   C1515981:And [Idea or Concept]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1705946:Coil [Medical Device]
   753   C2826302:TERM [Intellectual Product]

Phrase: "is"

Phrase: "subtracted from ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1719767:Subtract [Intellectual Product]
   799   C2348589:Subtract [Phenomenon or Process]

Phrase: ")"

Phrase: "Charge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007961:Charge [Quantitative Concept]
  1000   C1706211:Charge [Organism Attribute]

Phrase: "is"

Phrase: "the difference in charge,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: "are"

Phrase: "empirically determined constants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1547014:*Constant [Quantitative Concept]
   793   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.60: Synthetic 42-Residue PeptidesCrude peptides were purchased from the Keck Institute, Yale University, and were then purified using reverse phase HPLC. 

Phrase: "Synthetic 42-Residue PeptidesCrude peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   804   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "purchased from the Keck Institute,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021622:institute [Organization]
   760   C0869011:purchased [Activity]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Yale University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "reverse phase HPLC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]
Processing 00000000.tx.61: Their identities were confirmed by mass spectrometry, and purity was assessed by analytical reverse phase HPLC. 

Phrase: "Their identities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0424215:identities [Mental Process]
   966 E C2003939:Identity [Finding]

Phrase: "were"

Phrase: "confirmed by mass spectrometry,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0037813:Mass Spectrometry [Laboratory Procedure]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0436196:Spectrometry [Laboratory Procedure]
   770   C0577559:Mass [Finding]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "purity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882508:Purity [Quantitative Concept]
   928 E C2247561:PurE [Molecular Function]

Phrase: "was"

Phrase: "assessed by analytical reverse phase HPLC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0936012:Analytical [Research Activity]
   753   C1516048:Assessed [Activity]
   753   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.62: The purities of the peptides were greater than 92%. 

Phrase: "The purities of the peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1882508:Purity [Quantitative Concept]

Phrase: "were"

Phrase: "greater than 92%."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.63: After purification, peptides were lyophilized and dissolved in hexafluoroisopropanol (HFIP). 

Phrase: "After purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "lyophilized"

Phrase: "and"

Phrase: "dissolved in hexafluoroisopropanol (HFIP)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0062622:hexafluoroisopropanol [Organic Chemical]
   756   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.64: HFIP was removed by blowing argon over the sample. 

Phrase: "HFIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062622:hexafluoroisopropanol [Organic Chemical]

Phrase: "was"

Phrase: "removed by blowing argon"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003781:Argon [Element, Ion, or Isotope]
   770   C0413399:blowing [Injury or Poisoning]
   770   C0849355:Removed [Qualitative Concept]
   770   C1948015:Argon [Eukaryote]
   737 E C0009170:Blow [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "over the sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.65: Samples were then dissolved in 100 l of Me2SO/500 l of 4 M NaOH. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dissolved in 100 l of Me2SO/500 l of 4 M NaOH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0441923:M+ [Intellectual Product]
   703   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.66: Concentrations were determined using the extinction coefficient of tyrosine. 

Phrase: "Concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the extinction coefficient of tyrosine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015347:extinction [Mental Process]
   760   C1707429:*Coefficient [Quantitative Concept]
Processing 00000000.tx.67: Aggregation of Mutant Peptides in VitroPeptides were dissolved at a concentration of 10 M in 50 mM NaH2PO4, 100 mM NaCl, 0.02% NaN3 (pH 7.3-7.4). 

Phrase: "Aggregation of Mutant Peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "in VitroPeptides"

Phrase: "were"

Phrase: "dissolved at a concentration of 10 M"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086045:Concentration [Mental Process]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1446561:Concentration [Quantitative Concept]
   714   C1549535:Dissolve [Functional Concept]

Phrase: "in 50 mM NaH2PO4,"

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.02% NaN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074721:NaN3 [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(pH 7.3-7.4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C2678549:PH-4 [Gene or Genome]
   853   C0601906:PH 3 [Pharmacologic Substance]
   840   C1882074:pH 7 [Qualitative Concept]
   804   C0020283:[pH] [Quantitative Concept]
   804   C0450407:ph+ [Finding]
   804   C0450408:ph++ [Finding]
   804   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.68: Following incubation at 30 C for 1 day, samples were centrifuged for 30 min at 60,000 x g. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation at 30 C"

Phrase: "for 1 day,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1442449:1 Day [Temporal Concept]
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "at 60,000 x g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.69: Half of the supernatant was removed and loaded onto reverse phase HPLC to quantify the monomer remaining in solution. 

Phrase: "Half of the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "loaded onto reverse phase HPLC to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C1555029:Reverse [Idea or Concept]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the monomer remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "in solution."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.70: To correlate peak size with concentration, a series of standards was run using a range of concentrations of the Asp41-Gln42 mutant. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate"

Phrase: "peak size with concentration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456389:size [Spatial Concept]

Phrase: "a series of standards"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "was"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a range of concentrations of the Asp41-Gln42 mutant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1514721:Range [Quantitative Concept]
   742   C2348147:Range [Quantitative Concept]
   742   C3542016:Range [Intellectual Product]
Processing 00000000.tx.71: The relationship between peak size and peptide concentration was confirmed using same concentrations of wild type A42, the hydrophobic mutant Leu41-Leu42, and the green control mutant Ser19-Pro34. 

Phrase: "The relationship between peak size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "peptide concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "same concentrations of wild type A42,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "the hydrophobic mutant Leu41-Leu42,"

Phrase: "and"

Phrase: "the green control mutant Ser19-Pro34."
Processing 00000000.tx.72: Thioflavin T AssayBecause the kinetics of fibril formation can be affected by small quantities of seeds, preexisting seeds were removed by the following treatment (27). 

Phrase: "Thioflavin T AssayBecause"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "the kinetics of fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022702:Kinetics [Natural Phenomenon or Process]
   760   C0220865:kinetics [Functional Concept]
   760   C2825046:Kinetics [Occupation or Discipline]

Phrase: "can"

Phrase: "be"

Phrase: "affected by small quantities of seeds,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0036563:Seed [Plant]
   753   C0392760:Affected [Functional Concept]
   753   C0700321:Small [Quantitative Concept]
   753   C1265611:QUANTITIES [Quantitative Concept]
   753   C1314939:Affected [Functional Concept]
   753   C1705192:Seed [Laboratory Procedure]
   753   C1882540:{Seed} [Quantitative Concept]
   753   C2346495:Seed [Conceptual Entity]
   719 E C0001721:Affect [Mental Process]
   719 E C1554108:Quantity [Intellectual Product]
   719 E C1561573:Quantity [Intellectual Product]

Phrase: "preexisting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347662:Preexisting [Qualitative Concept]

Phrase: "seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0036563:Seed [Plant]
  1000   C1705192:Seed [Laboratory Procedure]
  1000   C1882540:{Seed} [Quantitative Concept]
  1000   C2346495:Seed [Conceptual Entity]
   944 E C1519232:Seminal [Clinical Attribute]

Phrase: "were"

Phrase: "removed by the following treatment"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0849355:Removed [Qualitative Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.73: Lyophilized peptides were dissolved in trifluoroacetic acid at 1 mg/ml and sonicated for 15 min. 

Phrase: "Lyophilized peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "dissolved in trifluoroacetic acid at 1 mg/ml"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0040982:Trifluoroacetic Acid [Organic Chemical]
   770   C0439294:mg ml [Quantitative Concept]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0439269:mg% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   711   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "sonicated for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]
Processing 00000000.tx.74: Trifluoroacetic acid was then removed by blowing argon over the sample. 

Phrase: "Trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040982:Trifluoroacetic Acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed by blowing argon"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003781:Argon [Element, Ion, or Isotope]
   770   C0413399:blowing [Injury or Poisoning]
   770   C0849355:Removed [Qualitative Concept]
   770   C1948015:Argon [Eukaryote]
   737 E C0009170:Blow [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "over the sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.75: The dry sample was resuspended in 2 ml of HFIP. 

Phrase: "The dry sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "resuspended in 2 ml of HFIP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0062622:hexafluoroisopropanol [Organic Chemical]
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.76: An aliquot corresponding to 0.5 mg of peptide was dried under argon and then dissolved in 300 l of Me2SO and mixed with 5 ml of 8 mM NaOH. 

Phrase: "An aliquot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510844:Aliquot [Quantitative Concept]

Phrase: "corresponding to 0.5 mg of peptide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0439269:mg% [Quantitative Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "dried under argon"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0003781:Argon [Element, Ion, or Isotope]
   790   C1512080:Dried [Qualitative Concept]
   790   C1948015:Argon [Eukaryote]
   790   C2827485:Dried [Body Substance]
   756 E C0011682:Dry [Natural Phenomenon or Process]
   756 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dissolved in 300 l of Me2SO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "mixed with 5 ml of 8 mM NaOH."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0205430:Mixed [Functional Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C3160715:Mixed [Finding]
   711 E C1421951:MIX [Gene or Genome]
   711 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.77: The solution was then centrifuged at 40,000 x g for 30 min to remove any insoluble material. 

Phrase: "The solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 40,000 x g"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1955160:40 g [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439509:/40 [Temporal Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 30 min to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456693:/30 min [Temporal Concept]
   901   C1442458:30 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "any insoluble material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]
Processing 00000000.tx.78: The supernatant was removed, and phosphate-buffered saline was added to a final concentration of 50 mM NaH2PO4, 100 mM NaCl, 0.02% NaN3. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to a final concentration of 50 mM NaH2PO4,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0086045:Concentration [Mental Process]
   742   C0205088:Final [Temporal Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1524062:Added [Functional Concept]
   742   C1546485:Final [Idea or Concept]
   708 E C1883712:Add [Functional Concept]

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.02% NaN3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074721:NaN3 [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.79: The pH was adjusted to 7.4-7.5 with 200 mM formic acid. 

Phrase: "The pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "adjusted to 7.4-7.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456081:Adjusted [Functional Concept]

Phrase: "with 200 mM formic acid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0885348:formic acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.80: 500-l aliquots were removed every 30 min and mixed with 2.4 ml of a ThT solution (7 M thioflavin T, 50 mM glycine-NaOH (pH 8.5)). 

Phrase: "500-l aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "every 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "mixed with 2.4 ml of a ThT solution"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0037633:Solution [Substance]
   739   C0205430:Mixed [Functional Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C0525069:Solution [Biomedical or Dental Material]
   739   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C3160715:Mixed [Finding]
   706 E C1421951:MIX [Gene or Genome]
   706 E C1720722:Mix [Qualitative Concept]

Phrase: "(7 M thioflavin T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "50 mM glycine-NaOH"

Phrase: "(pH 8.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.81: Fluorescence was measured with excitation at 450 nm, and emission at 490 nm.  

Phrase: "Fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured with excitation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0549255:Excitation [Activity]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "at 450 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "emission at 490 nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233929:Emission [Body Substance]
   770   C2349995:Emission [Substance]
Processing 00000000.tx.82: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  A High Throughput Screen for A AggregationRandom mutagenesis of position 41 and 42 can produce 400 possible sequences (including wild type). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A High Throughput Screen for A AggregationRandom mutagenesis of position 41"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0220908:screen [Health Care Activity]
   738   C1305399:screen [Functional Concept]
   738   C1705053:Screen [Medical Device]

Phrase: "and"

Phrase: "42"

Phrase: "can"

Phrase: "produce"

Phrase: "400 possible sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.83: Synthesis, purification, and characterization of the aggregation behavior of all 400 peptides would be laborious and extremely expensive, particularly because the A42 peptide is notoriously difficult to synthesize and purify (28, 29). 

Phrase: "Synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of the aggregation behavior of all 400 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: "would"

Phrase: "be"

Phrase: "laborious"

Phrase: "and"

Phrase: "extremely expensive, particularly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0680864:expense [Quantitative Concept]

Phrase: "because"

Phrase: "the A42 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "notoriously difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332218:Difficult [Qualitative Concept]
   755 E C1299586:Difficulty [Finding]

Phrase: "synthesize"

Phrase: "and"

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.84: Therefore, we developed a high throughput screen using GFP as a reporter tag (21). 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "developed"

Phrase: "a high throughput screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220908:screen [Health Care Activity]
   827   C1305399:screen [Functional Concept]
   827   C1705053:Screen [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GFP as a reporter tag (21"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   776   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C1818826:protein tag [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.85: The folding of GFP and the formation of its active chromaphore occur relatively slowly (30). 

Phrase: "The folding of GFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0162847:folding protein [Molecular Function]
   753   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the formation of its active chromaphore"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "relatively slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439834:Slowly [Qualitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.86: Therefore, peptides or proteins fused to the N terminus of GFP can have a dramatic impact on fluorescence. 

Phrase: "Therefore,"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fused to the N terminus of GFP"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   766   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332583:Green [Qualitative Concept]
   742   C0699952:Fused [Functional Concept]
   708 E C1414861:FUSE [Gene or Genome]
   708 E C1708111:Fuse [Manufactured Object]

Phrase: "can"

Phrase: "have"

Phrase: "a dramatic impact on fluorescence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.87: Sequences that aggregate rapidly prevent formation of a correctly folded fluorescent GFP. 

Phrase: "Sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "formation of a correctly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "fluorescent GFP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.88: In contrast, sequences that are soluble or aggregate slowly allow GFP to fold into its native fluorescent structure. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "or"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "GFP to fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   838   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "into its native fluorescent structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.89: In a systematic study using 20 different test proteins, Waldo et al. 

Phrase: "In a systematic study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "20 different test proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0788300:test protein [Medical Device]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Waldo et al."
Processing 00000000.tx.90: (31) demonstrated that the fluorescence of E. coli cells expressing fusions to the N terminus of GFP correlated with the solubility of the test protein expressed alone. 

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the fluorescence of E. coli cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "expressing"

Phrase: "fusions to the N terminus of GFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   742   C0332466:fusions [Functional Concept]
   742   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "correlated with the solubility of the test protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0788300:test protein [Medical Device]
   767   C1441746:Solubility test [Laboratory Procedure]
   744   C0022885:Test [Laboratory Procedure]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0037628:Solubility [Qualitative Concept]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C1707520:Correlated [Qualitative Concept]

Phrase: "expressed"

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.91: We have shown previously that the fluorescence of A42-GFP fusions can be used as an unbiased screen for the sequence determinants of A amyloidogenesis (21). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that"

Phrase: "the fluorescence of A42-GFP fusions"

Phrase: "can"

Phrase: "be"

Phrase: "used as an unbiased screen"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0220908:screen [Health Care Activity]
   760   C1273517:used [Finding]
   760   C1305399:screen [Functional Concept]
   760   C1705053:Screen [Medical Device]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for the sequence determinants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521761:Determinant [Functional Concept]

Phrase: "of A amyloidogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706803:Amyloidogenesis [Cell or Molecular Dysfunction]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.92: Colonies of E. coli expressing fusions to wild type A42 or to mutants of A42 that favor rapid aggregation are white. 

Phrase: "Colonies of E. coli expressing fusions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439158:colonies [Quantitative Concept]
   719 E C1947989:Colony [Cell]

Phrase: "to wild type A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or to mutants of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "rapid aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "are"

Phrase: "white."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]
Processing 00000000.tx.93: In contrast, colonies expressing fusions to soluble (or slowly aggregating) mutants of A42 are green. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439158:colonies [Quantitative Concept]
   966 E C1947989:Colony [Cell]

Phrase: "expressing"

Phrase: "fusions to soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332466:fusions [Functional Concept]
   790   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "or"

Phrase: "slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "aggregating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregating [Qualitative Concept]

Phrase: ")"

Phrase: "mutants of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.94: Here we used A42-GFP fusions to monitor the phenotypic variation resulting from amino acid substitutions at positions 41 and 42 of A42. 

Phrase: "Here"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "A42-GFP fusions to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332466:fusions [Functional Concept]
   799   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the phenotypic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836717:Phenotypic variation [Finding]
   861   C0205419:Variation [Qualitative Concept]

Phrase: "resulting from amino acid substitutions"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726   C1555721:Substitution [Idea or Concept]
   726   C1706204:Substitution [Activity]
   726 E C2825142:Result [Finding]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42 of A42."
Processing 00000000.tx.95: This enabled a high throughput screen in which more than 2500 colonies could be screened per plate. 

Phrase: "This enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "a high throughput screen in which more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220908:screen [Health Care Activity]
   748   C1305399:screen [Functional Concept]
   748   C1705053:Screen [Medical Device]

Phrase: "than 2500 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "could"

Phrase: "be"

Phrase: "screened per plate."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0005971:Plate [Medical Device]
   790   C1139930:plate [Medical Device]
   790   C3537155:Plate [Manufactured Object]
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]
Processing 00000000.tx.96: To ensure that the screen had sufficient dynamic range to distinguish a range of phenotypes, we first performed pilot experiments using fusions of GFP to the wild type sequences of either A42 or A40. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "had"

Phrase: "sufficient dynamic range to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C2986743:Dynamic Range [Quantitative Concept]
   812   C0729333:Dynamic [Functional Concept]
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: "distinguish"

Phrase: "a range of phenotypes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "we first performed pilot experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fusions of GFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0332466:fusions [Functional Concept]
   760   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "to the wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "sequences of either A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "or"

Phrase: "A40."
Processing 00000000.tx.97: (The latter construct can be considered as the null mutant in which residues 41 and 42 are not merely substituted but deleted entirely.) 

Phrase: "("

Phrase: "The latter construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "can"

Phrase: "be"

Phrase: "considered as the null mutant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0456148:Null [Quantitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C0750591:considered [Idea or Concept]

Phrase: "in which residues 41"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "42"

Phrase: "are"

Phrase: "not merely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "substituted"

Phrase: "but"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "entirely."

Phrase: ")"
Processing 00000000.tx.98: At 37 C both fusions produced white colonies. 

Phrase: "At 37 C"

Phrase: "both fusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332466:fusions [Functional Concept]
  1000   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "produced"

Phrase: "white colonies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]
Processing 00000000.tx.99: Thus, at this temperature, the screen does not have sufficient dynamic range. 

Phrase: "Thus,"

Phrase: "at this temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "the screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "sufficient dynamic range."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2986743:Dynamic Range [Quantitative Concept]
   827   C0729333:Dynamic [Functional Concept]
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]
Processing 00000000.tx.100: In contrast, at 30 C, colonies expressing fusions to A42 were white, whereas those expressing fusions to A40 were green. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "at 30 C,"

Phrase: "colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439158:colonies [Quantitative Concept]
   966 E C1947989:Colony [Cell]

Phrase: "expressing"

Phrase: "fusions to A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332466:fusions [Functional Concept]
   790   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "white,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "whereas"

Phrase: "those expressing fusions to A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332466:fusions [Functional Concept]
   760   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.101: Thus, at this lower temperature, where expression and subsequent aggregation are slower, the difference in aggregation propensity between A40 and A42 is easily distinguished. 

Phrase: "Thus,"

Phrase: "at this lower temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "where expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "subsequent aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "are"

Phrase: "slower,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439834:Slow [Qualitative Concept]

Phrase: "the difference in aggregation propensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "between A40"

Phrase: "and"

Phrase: "A42"

Phrase: "is"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "distinguished."
Processing 00000000.tx.102: Further pilot experiments showed that at 37 C, virtually all mutations at positions 41 and 42 produced white colonies, whereas at 30 C libraries of mutants at 41 and 42 produced both green and white colonies. 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "pilot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0473169:Pilot [Professional or Occupational Group]
  1000   C1414316:PILOT [Gene or Genome]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that at 37 C,"

Phrase: "virtually"

Phrase: "all mutations at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "42 produced white colonies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439158:colonies [Quantitative Concept]
   779 E C1947989:Colony [Cell]

Phrase: "whereas at 30 C libraries of mutants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0023621:Libraries [Manufactured Object,Organization]
   748   C0596988:mutants [Cell or Molecular Dysfunction]
   714 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   714 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at 41"

Phrase: "and"

Phrase: "42"

Phrase: "produced"

Phrase: "both green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "and"

Phrase: "white colonies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]
Processing 00000000.tx.103: Because expression at 30 C provided excellent dynamic range, all further experiments were performed at this temperature. 

Phrase: "Because"

Phrase: "expression at 30 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "excellent dynamic range,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2986743:Dynamic Range [Quantitative Concept]
   827   C0729333:Dynamic [Functional Concept]
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: "all further experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed at this temperature."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.104: A Random Library of Mutants at Positions 41 and 42A library of random mutants at positions 41 and 42 of A42 was constructed using synthetic oligonucleotides to incorporate random bases (NNN) at the final 2 codons of a synthetic gene encoding A42 (see "Materials and Methods"). 

Phrase: "A Random Library of Mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023621:Library [Manufactured Object,Organization]
   760   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at Positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42A library of random mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023621:Library [Manufactured Object,Organization]
   760   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42 of A42"

Phrase: "was"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synthetic oligonucleotides to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "incorporate"

Phrase: "random bases"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "(NNN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0067113:NNN [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ")"

Phrase: "at the final 2 codons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]

Phrase: "of a synthetic gene encoding A42"

Phrase: "(see ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: The library of mutant genes of A42 was then fused to the 5' end of a gene encoding GFP. 

Phrase: "The library of mutant genes of A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0017272:Gene Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fused to the 5' end of a gene"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   767   C1704837:END Gene [Gene or Genome]
   750   C1414861:FUSE gene [Gene or Genome]
       E   FUSE
   744   C0017337:Gene [Gene or Genome]
   744   C0444930:End [Spatial Concept]
   744   C0699952:Fused [Functional Concept]
   744   C2746065:End [Temporal Concept]
   711 E C1708111:Fuse [Manufactured Object]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "GFP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   976   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.106: In this construct, the A42 sequence is separated from GFP by a 12-residue linker encoding the sequence Gly-Ser-Ala-Gly-Ser-Ala-Ala-Gly-Ser-Gly-Glu-Phe (31). 

Phrase: "In this construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "the A42 sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "separated from GFP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   838   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086972:Separated [Finding]
   760   C0332583:Green [Qualitative Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "by a 12-residue linker"

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the sequence Gly-Ser-Ala-Gly-Ser-Ala-Ala-Gly-Ser-Gly-Glu-Phe (31"
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   875   C0619372:Gly-Ser-Phe [Amino Acid, Peptide, or Protein]
   874   C0061706:Gly-Ala-Phe [Amino Acid, Peptide, or Protein]
   874   C0061738:Gly-Phe [Amino Acid, Peptide, or Protein]
   866   C0068000:Gly-Glu [Amino Acid, Peptide, or Protein]
   859   C0061714:Gly-Gly-Gly-Gly [Amino Acid, Peptide, or Protein]
   858   C0606135:Ala-Phe [Amino Acid, Peptide, or Protein]
   850   C0051079:Ala-Glu [Amino Acid, Peptide, or Protein]
   842   C0061713:Gly-Gly-Gly [Amino Acid, Peptide, or Protein]
   820   C0051069:Ala-Ala-Ala [Amino Acid, Peptide, or Protein]
   810   C0051078:Ala-Ala [Amino Acid, Peptide, or Protein]
   806   C0061730:Gly-Ser-Ala [Amino Acid, Peptide, or Protein]
   802   C0083663:Gly-Ala [Amino Acid, Peptide, or Protein]
   786   C0004793:Sequence [Nucleotide Sequence]
   786   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   786   C0031453:Phe [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   786   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   786   C0162326:Sequence [Nucleotide Sequence]
   786   C0162327:Sequence [Nucleotide Sequence]
   786   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0450355:31 [Intellectual Product]
   786   C1519249:Sequence [Functional Concept]
   714   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]
   714 E C1548958:Sequential [Idea or Concept]
   714 E C1705294:Sequential [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.107: The library of fusions was then transformed into XL1 Blue cells. 

Phrase: "The library of fusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023621:Library [Manufactured Object,Organization]
   770   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transformed into XL1 Blue cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C1260957:Blue [Qualitative Concept]
   760   C1510411:Transformed [Pathologic Function]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.108: Transformation yielded more than 5000 colonies. 

Phrase: "Transformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040682:Transformation [Cell Function]
  1000   C1510411:Transformation [Pathologic Function]
  1000   C1705163:Transformation [Research Activity]

Phrase: "yielded"

Phrase: "more than 5000 colonies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205172:More [Functional Concept]
   770   C0439158:colonies [Quantitative Concept]
   737 E C1947989:Colony [Cell]
Processing 00000000.tx.109: Because there are only 400 possible combinations of amino acids positions 41 and 42, this library is adequate to sample all (or nearly all) of the possible sequences (TABLE ONE). 

Phrase: "Because"

Phrase: "there"

Phrase: "are"

Phrase: "only 400 possible combinations of amino acids"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0453882:Combinations [Manufactured Object]
   714 E C0205195:Combination [Qualitative Concept]
   714 E C1947911:Combination [Physical Object]

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "41"

Phrase: "and"

Phrase: "42,"

Phrase: "this library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023621:Library [Manufactured Object,Organization]
  1000   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "adequate to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205410:Adequate [Qualitative Concept]
   861   C0205411:Adequate [Qualitative Concept]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "all ("

Phrase: "or"

Phrase: "nearly"

Phrase: "all) of the possible sequences"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0332149:Possible [Qualitative Concept]
   760   C0444868:All [Quantitative Concept]
   760   C1705910:Possible [Qualitative Concept]
   760   C2362652:Possible [Qualitative Concept]
   760   C3539085:All [Idea or Concept]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "(TABLE ONE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.110: The library was then extracted from XL1 Blue cells and transformed into BL21(DE3) cells for protein expression and high throughput screening. 

Phrase: "The library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023621:Library [Manufactured Object,Organization]
  1000   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "extracted from XL1 Blue cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C3282337:Cells [Cell]
   760   C3541890:EXTRACTED [Finding]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "transformed into BL21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450615:BL21 [Body Location or Region]
   790   C1510411:Transformed [Pathologic Function]

Phrase: "(DE3"

Phrase: ")"

Phrase: "cells for protein expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "high throughput screening."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0872187:High Throughput Screening [Diagnostic Procedure]
   827   C0205250:High [Qualitative Concept]
   827   C0220908:Screening [Health Care Activity]
   827   C0220909:screening [Functional Concept]
   827   C1299351:High [Qualitative Concept]
   827   C1698960:screening [Intellectual Product]
   827   C1710031:Screening [Diagnostic Procedure]
   827   C1710477:SCREENING [Research Activity]
   827   C2700149:HIGH [Intellectual Product]
   793 E C1305399:screen [Functional Concept]
   793 E C1705053:Screen [Medical Device]
Processing 00000000.tx.111: View this table: [in this window] [in a new window]  TABLE ONE Diversity of the libraries The number of colonies for each library was counted after transformation into XL1-Blue cells. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE ONE Diversity of the libraries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1511998:Diversity Library [Manufactured Object]
   753   C1880371:Diversity [Qualitative Concept]

Phrase: "The number of colonies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "for each library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023621:Library [Manufactured Object,Organization]
  1000   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "counted after transformation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0040682:Transformation [Cell Function]
   790   C1510411:Transformation [Pathologic Function]
   790   C1705163:Transformation [Research Activity]
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "into XL1-Blue cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.112: For each library, the number of observed colonies was much larger than number of possible amino acid combinations. 

Phrase: "For each library,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023621:Library [Manufactured Object,Organization]
  1000   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the number of observed colonies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "much larger than number of possible amino acid combinations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0443228:larger [Quantitative Concept]
   742   C0549177:Larger [Quantitative Concept]
   742   C1704243:Larger [Quantitative Concept]
Processing 00000000.tx.113: Consequently, all (or nearly all) of the possible sequences are represented in the experimental libraries.  

Phrase: "Consequently,"

Phrase: "all ("

Phrase: "or"

Phrase: "nearly"

Phrase: "all) of the possible sequences"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0332149:Possible [Qualitative Concept]
   760   C0444868:All [Quantitative Concept]
   760   C1705910:Possible [Qualitative Concept]
   760   C2362652:Possible [Qualitative Concept]
   760   C3539085:All [Idea or Concept]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: "represented in the experimental libraries."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0023621:Libraries [Manufactured Object,Organization]
   760   C1517586:Experimental [Qualitative Concept]
   726 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   726 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C1882932:Represent [Activity]
Processing 00000000.tx.114: To assess the effect of amino acid substitutions at residues 41 and 42 on the aggregation of A42, the library of A42-GFP fusions was expressed at 30 C, and the resulting colonies were characterized. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effect of amino acid substitutions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0680963:substitution effect [Functional Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "at residues 41"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "42 on the aggregation of A42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "the library of A42-GFP fusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0023621:Library [Manufactured Object,Organization]
   744   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "expressed at 30 C,"

Phrase: "and"

Phrase: "the resulting colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.115: In a typical experiment, 1520 colonies were analyzed. 

Phrase: "In a typical experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "1520 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.116: Of these, 140 colonies (9%) were white, similar to colonies expressing GFP fusions to wild type A42. 

Phrase: "Of these,"

Phrase: "140 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "(9%"

Phrase: ")"

Phrase: "were"

Phrase: "white, similar to colonies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "expressing"

Phrase: "GFP fusions to wild type A42."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0332466:fusions [Functional Concept]
   744   C1293131:fusions [Therapeutic or Preventive Procedure]
Processing 00000000.tx.117: The remaining 1380 colonies (91%) showed some level of green fluorescence (TABLE TWO). 

Phrase: "The remaining 1380 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "(91%"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "some level of green fluorescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "(TABLE TWO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.118: 34 clones from this library were chosen arbitrarily for further characterization by sequence analysis and fluorescence measurements. 

Phrase: "34 clones from this library"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0009013:Clones [Cell]
   726 E C1522642:Clone [Tissue]

Phrase: "were"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "arbitrarily for further characterization"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1517331:Further [Spatial Concept]
   770   C1880022:Characterization [Activity]
   737 E C0205108:far [Spatial Concept]

Phrase: "by sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "fluorescence measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]
Processing 00000000.tx.119: The correlation between sequence and fluorescence is shown in Fig. 

Phrase: "The correlation between sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.120: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.121: View this table: [in this window] [in a new window]  TABLE TWO Green/white phenotypic screening of colonies expressing A(42)-GFP fusions Colonies transformed into BL21(DE3) with plasmids encoding A42-GFP fusions were screened for fluorescence after 4 h of induction at 30 C. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE TWO Green/white phenotypic screening of colonies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0220908:Screening [Health Care Activity]
   744   C0220909:screening [Functional Concept]
   744   C1698960:screening [Intellectual Product]
   744   C1710031:Screening [Diagnostic Procedure]
   744   C1710477:SCREENING [Research Activity]

Phrase: "expressing"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(42"

Phrase: ")-"

Phrase: "GFP fusions Colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439158:colonies [Quantitative Concept]
   771 E C1947989:Colony [Cell]

Phrase: "transformed into BL21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450615:BL21 [Body Location or Region]
   790   C1510411:Transformed [Pathologic Function]

Phrase: "(DE3"

Phrase: ")"

Phrase: "with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "A42-GFP fusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332466:fusions [Functional Concept]
   804   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "screened for fluorescence"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0016315:Fluorescence [Natural Phenomenon or Process]
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]
   718 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "after 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "at 30 C."
Processing 00000000.tx.122: When positions 41 and 42 were both randomized, 91% of colonies were green fluorescent, indicating that many mutations disrupted aggregation. 

Phrase: "When"

Phrase: "positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42"

Phrase: "were"

Phrase: "both"

Phrase: "randomized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034656:randomized [Research Activity]

Phrase: ","

Phrase: "91% of colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0439158:colonies [Quantitative Concept]
   756 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "green fluorescent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "indicating"

Phrase: "that"

Phrase: "many mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.123: When only hydrophobic residues were allowed at positions 41 and 42, all colonies were white, indicating that random hydrophobic residues support aggregation. 

Phrase: "When"

Phrase: "only hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "allowed at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0683607:allowed [Social Behavior]
   770   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "42,"

Phrase: "all colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439158:colonies [Quantitative Concept]
   966 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "white,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "indicating"

Phrase: "that random hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.124: In contrast, when only hydrophilic residues were allowed at positions 41 and 42, 87% of the colonies (4160 colonies) were green. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "only hydrophilic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "allowed at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0683607:allowed [Social Behavior]
   770   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "42,"

Phrase: "87% of the colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439158:colonies [Quantitative Concept]
   737 E C1947989:Colony [Cell]

Phrase: "(4160 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: ")"

Phrase: "were"

Phrase: "green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.125: The remaining 13% (640 colonies) were white because they did not express the fusion protein. 

Phrase: "The remaining 13%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "(640 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: ")"

Phrase: "were"

Phrase: "white"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "because"

Phrase: "they"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "the fusion protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.126: Thus, random hydrophilic residues disrupt aggregation. 

Phrase: "Thus,"

Phrase: "random hydrophilic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.127: The other libraries are described in the text.  

Phrase: "The"

Phrase: "other libraries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0023621:Libraries [Manufactured Object,Organization]
   966 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   966 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "described in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.128: The Effect of Hydrophobicity at Residues 41 and 42As shown in Fig. 

Phrase: "The Effect of Hydrophobicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "at Residues 41"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "42As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.129: 1A, GFP fusions to mutants with hydrophobic residues at positions 41 and 42 display low fluorescence, similar to fusions to wild type (Ile41-Ala42)A42. 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "GFP fusions to mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0332466:fusions [Functional Concept]
   753   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "with hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "low fluorescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "similar to fusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "to wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(Ile41-Ala42"

Phrase: ")"

Phrase: "A42."
Processing 00000000.tx.130: In contrast, fusions to mutants with hydrophilic residues at positions 41 and 42 show high fluorescence, similar to fusions to A40. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "fusions to mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332466:fusions [Functional Concept]
   790   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "with hydrophilic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "high fluorescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "similar to fusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "to A40."
Processing 00000000.tx.131: These results suggest that hydrophobic side chains at positions 41 and 42 increase the propensity of A42 to aggregate. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that hydrophobic side chains at positions 41"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0337112:chains [Manufactured Object]
   748   C0441987:Side [Spatial Concept]
   748   C1524075:Chains [Idea or Concept]

Phrase: "and"

Phrase: "42"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the propensity of A42 to"

Phrase: "aggregate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.132: To confirm this correlation, we produced two additional libraries of mutants. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this correlation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlation [Qualitative Concept]

Phrase: "we"

Phrase: "produced"

Phrase: "two additional libraries of mutants."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0023621:Libraries [Manufactured Object,Organization]
   726 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   726 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.133: In one library, residues 41 and 42 were mutated to a combinatorial mixture of hydrophobic residues. 

Phrase: "In one library,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "residues 41"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "42"

Phrase: "were"

Phrase: "mutated to a combinatorial mixture of hydrophobic residues."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0439962:Mixture [Substance]
   744   C0598629:Hydrophobic [Qualitative Concept]
   744   C1705285:Mutated [Cell or Molecular Dysfunction]
   711 E C1513776:Mutate [Genetic Function]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.134: In the other library, these residues were mutated to a combinatorial mixture of hydrophilic residues. 

Phrase: "In the"

Phrase: "other library,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023621:Library [Manufactured Object,Organization]
  1000   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "these residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "mutated to a combinatorial mixture of hydrophilic residues."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0439962:Mixture [Substance]
   744   C0475370:Hydrophilic [Qualitative Concept]
   744   C1705285:Mutated [Cell or Molecular Dysfunction]
   711 E C1513776:Mutate [Genetic Function]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.135: The hydrophobic library was constructed using the degenerate DNA codon NTN to encode a mixture of nonpolar residues including Ile, Leu, Val, Met, and Phe (32). 

Phrase: "The hydrophobic library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the degenerate DNA codon NTN to"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a mixture of nonpolar residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Ile,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Ile [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:ILE [Laboratory Procedure]

Phrase: "Leu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Val,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: ","

Phrase: "and"

Phrase: "Phe (32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031453:Phe [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.136: The hydrophilic library was constructed using the NAN codon to encode a mixture of polar residues including Glu, Gln, Asp, Asn, Lys, His, and Tyr (where N denotes a mixture of the four DNA bases). 

Phrase: "The hydrophilic library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NAN codon to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a mixture of polar residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Glu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Gln,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Asp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206293:Asp [Reptile]
  1000   C3541260:ASP [Gene or Genome]

Phrase: "Asn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003995:Asn [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Lys,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "His,"

Phrase: "and"

Phrase: "Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1421250:TYR [Gene or Genome]

Phrase: "(where N"

Phrase: "denotes"

Phrase: "a mixture of the four DNA bases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439962:Mixture [Substance]

Phrase: ")."
Processing 00000000.tx.137: Both libraries were plated, and protein was expressed at 30 C. 

Phrase: "Both libraries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0023621:Libraries [Manufactured Object,Organization]
   966 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   966 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: ","

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "expressed at 30 C."
Processing 00000000.tx.138: For the 41/42-hydrophobic library, >5000 colonies were analyzed and none were green. 

Phrase: "For the 41/42-hydrophobic library,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0023621:Library [Manufactured Object,Organization]
   812   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ">5000 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "none"

Phrase: "were"

Phrase: "green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.139: Thus, randomly chosen hydrophobic residues at positions 41 and 42 support A42 aggregation. 

Phrase: "Thus,"

Phrase: "randomly chosen hydrophobic residues at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "42 support A42 aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332621:Aggregation [Functional Concept]
   812   C0439168:% aggregation [Quantitative Concept]
   741 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.140: In contrast, for the 41/42-hydrophilic library, 4800 colonies were analyzed, and 87% of them (4160 colonies) were green. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "for the 41/42-hydrophilic library,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0023621:Library [Manufactured Object,Organization]
   812   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "4800 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ","

Phrase: "and"

Phrase: "87% of them"

Phrase: "(4160 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439158:colonies [Quantitative Concept]
   827 E C1947989:Colony [Cell]

Phrase: ")"

Phrase: "were"

Phrase: "green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.141: This result indicates that randomly chosen polar residues at positions 41 and 42 disrupt the aggregation of A42. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "indicates"

Phrase: "that randomly chosen polar residues at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "42"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the aggregation of A42."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.142: From the hydrophilic library, only 640 colonies (13%) were white. 

Phrase: "From the hydrophilic library,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023621:Library [Manufactured Object,Organization]
   861   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "only 640 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "(13%"

Phrase: ")"

Phrase: "were"

Phrase: "white."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]
Processing 00000000.tx.143: We tested 64 of these colonies for expression of the A42-GFP fusions, and we found that all but one of them did not express the fusion protein. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "64 of these colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439158:colonies [Quantitative Concept]
   737 E C1947989:Colony [Cell]

Phrase: "for expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the A42-GFP fusions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332466:fusions [Functional Concept]
   804   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "all"

Phrase: "but"

Phrase: "one of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "the fusion protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.144: (Because we used the NAN degenerate codon at positions 41 and 42, it was expected that the library would contain stop codons, which prevent protein expression.) 

Phrase: "("

Phrase: "Because"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NAN degenerate codon at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0009221:Codon [Nucleotide Sequence]
   748   C1095825:Codon [Plant]

Phrase: "and"

Phrase: "42,"

Phrase: "it"

Phrase: "was"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that"

Phrase: "the library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023621:Library [Manufactured Object,Organization]
  1000   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "would"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "stop codons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242611:Stop Codon [Nucleotide Sequence]
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "which"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "protein expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"
Processing 00000000.tx.145: The other white colony expressed normal levels of the fusion protein. 

Phrase: "The"

Phrase: "other white colony"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439158:colony [Quantitative Concept]
   861   C1947989:Colony [Cell]

Phrase: "expressed"

Phrase: "normal levels of the fusion protein."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.146: Sequence analysis of this clone revealed that it had arginine at both positions 41 and 42. 

Phrase: "Sequence analysis of this clone"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0936012:Analysis [Research Activity]
   760   C1519249:Sequence [Functional Concept]
   760   C1524024:analysis [Functional Concept]
   747   C1880109:Clonality Analysis [Molecular Biology Research Technique]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "had"

Phrase: "arginine at both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "41"

Phrase: "and"

Phrase: "42."
Processing 00000000.tx.147: Thus, although most randomly chosen polar residues at positions 41 and 42 interfere with A aggregation, arginine is somehow special and allows aggregation (see below). 

Phrase: "Thus,"

Phrase: "although"

Phrase: "most randomly chosen polar residues at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "42"

Phrase: "interfere with A aggregation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
   770   C0521102:Interfere [Qualitative Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "somehow special"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205555:Special [Qualitative Concept]

Phrase: "and"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.148: View larger version (24K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.149: Fluorescence of A42-GFP fusions. 

Phrase: "Fluorescence of A42-GFP fusions."
Processing 00000000.tx.150: Cells were cultured in liquid media, and protein expression was induced at 30 C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in liquid media,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   802   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0302908:Liquid [Substance]
   770   C1254021:Media [Tissue]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1561501:Liquid NOS [Substance]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737   C2242979:Culture [Laboratory Procedure]
   737 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "induced at 30 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205263:Induced [Functional Concept]
Processing 00000000.tx.151: After induction, cells were diluted in buffer, and fluorescence was measured at 510 nm. 

Phrase: "After induction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "diluted in buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured at 510 nm."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.152: A, mutants with hydrophobic residues at positions 41 and 42 show lower fluorescence, consistent with higher levels of aggregation preventing the formation of the GFP chromaphore. 

Phrase: "A,"

Phrase: "mutants with hydrophobic residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "lower fluorescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "consistent with higher levels of aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the formation of the GFP chromaphore."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597295:protein formation [Molecular Function]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
Processing 00000000.tx.153: B, mutants with -sheet breakers (Pro or Gly) show a high level of fluorescence. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "mutants with -sheet breakers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(Pro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2987124:PRO [Intellectual Product]

Phrase: "or"

Phrase: "Gly)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a high level of fluorescence."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.154: The Glu41-Pro42 mutant shows an exceptional level of fluorescence, indicative of a very low propensity to aggregate, resulting from both charged and proline residues.  

Phrase: "The Glu41-Pro42 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an exceptional level of fluorescence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "indicative of a very low propensity to"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: ","

Phrase: "resulting from both"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "charged"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]
   966 E C0007961:Charge [Quantitative Concept]

Phrase: "and"

Phrase: "proline residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.155: Effect of the -Sheet Propensity of Residues 41 and 42Amyloid structures are dominated by -sheet secondary structure (33, 34), and previous studies suggested a strong correlation between the tendency of a sequence to form amyloid and the -sheet propensities of its component amino acids (26, 35-38). 

Phrase: "Effect of the -Sheet Propensity of Residues 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "42Amyloid structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "dominated by -sheet secondary structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0162807:Secondary Structure [Spatial Concept]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C0678594:Structure [Spatial Concept]
   760   C2349187:Sheet [Quantitative Concept]

Phrase: "(33,"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a strong correlation between the tendency of a sequence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the -sheet propensities of its component amino acids"

Phrase: "(26,"

Phrase: "35-38"

Phrase: ")."
Processing 00000000.tx.156: Of the 34 sequences analyzed above, 10 sequences contained proline or glycine at positions 41 or 42. 

Phrase: "Of the 34 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "above, 10 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "proline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "glycine at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0522461:Glycine [Plant]

Phrase: "or"

Phrase: "42."
Processing 00000000.tx.157: These residues have very low intrinsic propensities for -sheet structure (39). 

Phrase: "These residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "have"

Phrase: "very low intrinsic propensities for -sheet structure"

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.158: All 10 of these mutants displayed high levels of fluorescence (Fig. 1B). 

Phrase: "All 10 of these mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444868:All [Quantitative Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C3539085:All [Idea or Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "high levels of fluorescence"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.159: View larger version (17K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.160: Aggregation of synthetic 42-residue peptides. 

Phrase: "Aggregation of synthetic 42-residue peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.161: Peptides (10 M) were incubated at 30 C for 1 day. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(10"

Phrase: "M)"

Phrase: "were"

Phrase: "incubated at 30 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1 day."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1442449:1 Day [Temporal Concept]
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
Processing 00000000.tx.162: Samples were then centrifuged to remove precipitated aggregates, and the supernatant was run on reverse phase HPLC. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "precipitated aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "run on reverse phase HPLC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0008562:HPLC [Laboratory Procedure]
Processing 00000000.tx.163: The size of the peak indicates the amount of monomer that remained in solution. 

Phrase: "The size of the peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0456389:size [Spatial Concept]

Phrase: "indicates"

Phrase: "the amount of monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "that"

Phrase: "remained"

Phrase: "in solution."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.164: The hydrophilic mutant, Asp41-Gln42, and the non-C-terminal green control, Ser19-Pro34, yielded peaks at the elution time expected for monomers. 

Phrase: "The hydrophilic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Asp41-Gln42,"

Phrase: "and"

Phrase: "the non-C-terminal green control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]

Phrase: "Ser19-Pro34,"

Phrase: "yielded peaks at the elution time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0444505:peaks [Quantitative Concept]

Phrase: "expected for monomers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596973:monomers [Chemical Viewed Structurally]
   790   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.165: In contrast, wild type A42 and the hydrophobic mutant, Leu41-Leu42, showed almost no soluble peptide.  

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "wild type A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "the hydrophobic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Leu41-Leu42,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "almost"

Phrase: "no soluble peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.166: To study further the role of -sheet propensity at residues 41 and 42, we constructed additional libraries in which -sheet breakers were incorporated intentionally at position 41 or 42. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the role of -sheet propensity at residues 41"

Phrase: "and"

Phrase: "42,"

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "additional libraries in which -sheet breakers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0023621:Libraries [Manufactured Object,Organization]
   719 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "incorporated"

Phrase: "intentionally at position 41"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0733755:Position [Spatial Concept]

Phrase: "or"

Phrase: "42."
Processing 00000000.tx.167: Four libraries were constructed as follows: Pro41-Random42, Gly41-Random42, Random41-Pro42, and Random41-Gly42. 

Phrase: "Four libraries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0023621:Libraries [Manufactured Object,Organization]
   827 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Pro41-Random42,"

Phrase: "Gly41-Random42,"

Phrase: "Random41-Pro42,"

Phrase: "and"

Phrase: "Random41-Gly42."
Processing 00000000.tx.168: For each library, 20 different sequences are possible. 

Phrase: "For each library,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023621:Library [Manufactured Object,Organization]
  1000   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "20 different sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.169: To ensure extensive sampling, 178-320 colonies were analyzed for each library (TABLE TWO). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "extensive sampling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441621:Sampling [Diagnostic Procedure]
   861   C0870078:Sampling [Idea or Concept]

Phrase: "178-320 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "analyzed for each library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0023621:Library [Manufactured Object,Organization]
   770   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0936012:Analyzed [Research Activity]

Phrase: "(TABLE TWO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.170: For all four libraries, 90% of colonies were green. 

Phrase: "For all four libraries,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0023621:Libraries [Manufactured Object,Organization]
   827 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "90% of colonies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]
   790   C0439158:colonies [Quantitative Concept]
   756 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "green."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.171: The non-green colonies were assayed for protein expression, and none expressed the fusions. 

Phrase: "The non-green colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "assayed for protein expression,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1171362:protein expression [Genetic Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "none"

Phrase: "expressed"

Phrase: "the fusions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332466:fusions [Functional Concept]
  1000   C1293131:fusions [Therapeutic or Preventive Procedure]
Processing 00000000.tx.172: (As described above, non-expressers arise from stop codons encoded by the NNN degenerate codon.) 

Phrase: "("

Phrase: "As"

Phrase: "described above, non-expressers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1518422:Non [Functional Concept]

Phrase: "arise from stop codons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242611:Stop Codon [Nucleotide Sequence]
   770   C0009221:Codon [Nucleotide Sequence]
   770   C1095825:Codon [Plant]
   770   C1947925:Stop [Activity]
   770   C2746065:Stop [Temporal Concept]

Phrase: "encoded by the NNN degenerate codon."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009221:Codon [Nucleotide Sequence]
   753   C0011164:degenerate [Pathologic Function]
   753   C0067113:NNN [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0679058:encoded [Mental Process]
   753   C1095825:Codon [Plant]
   753   C1880269:Degenerate [Functional Concept]
   753   C2700640:Encoded [Activity]

Phrase: ")"
Processing 00000000.tx.173: These results indicate that the ability of residues 41 and 42 to form -sheet structure is important for A aggregation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the ability of residues 41"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "42 to"

Phrase: "form -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "sheet structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "important for A aggregation."
Processing 00000000.tx.174: Effect of the Site of MutationTo assess which of the two positions affects aggregation more significantly, we constructed two additional libraries. 

Phrase: "Effect of the Site of MutationTo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "which of the two positions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205448:Two [Quantitative Concept]
   760   C0733755:positions [Spatial Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "aggregation more significantly,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "two additional libraries."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0023621:Libraries [Manufactured Object,Organization]
   793 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   793 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.175: In each of these libraries one of the two C-terminal residues was held constant, whereas the other was randomized. 

Phrase: "In each"

Phrase: "of these libraries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0023621:Libraries [Manufactured Object,Organization]
   966 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   966 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "one of the two C-terminal residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "held"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1948036:held [Idea or Concept]
  1000   C2987518:hELD [Amino Acid, Peptide, or Protein]
   966 E C1553387:Hold [Idea or Concept]
   966 E C1948035:Hold [Activity]

Phrase: "constant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547014:*Constant [Quantitative Concept]
  1000   C1948059:Constant [Qualitative Concept]

Phrase: "whereas"

Phrase: "the other"

Phrase: "was"

Phrase: "randomized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034656:randomized [Research Activity]
Processing 00000000.tx.176: These libraries were called Ile41-Random42 and Random41-Ala42. 

Phrase: "These libraries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0023621:Libraries [Manufactured Object,Organization]
   966 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   966 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "Ile41-Random42"

Phrase: "and"

Phrase: "Random41-Ala42."
Processing 00000000.tx.177: (The wild type sequence is Ile41-Ala42.) 

Phrase: "("

Phrase: "The wild type sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "is"

Phrase: "Ile41-Ala42."

Phrase: ")"
Processing 00000000.tx.178: For each library, nearly 200 colonies were analyzed. 

Phrase: "For each library,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023621:Library [Manufactured Object,Organization]
  1000   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "nearly 200 colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.179: The Random41-Ala42 library yielded 37 white colonies (19% white), and 153 green colonies. 

Phrase: "The Random41-Ala42 library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023621:Library [Manufactured Object,Organization]
   827   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yielded"

Phrase: "37 white colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "(19% white"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "153 green colonies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]
Processing 00000000.tx.180: The Ile41-Random42 library yielded 44 white colonies (24% white), and 141 green colonies (TABLE TWO). 

Phrase: "The Ile41-Random42 library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023621:Library [Manufactured Object,Organization]
   827   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yielded"

Phrase: "44 white colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "(24% white"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "141 green colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "(TABLE TWO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.181: Because the fraction of white colonies in the two libraries is not significantly different, we conclude that the wild type residues at positions 41 and 42 contribute to aggregation to a similar extent. 

Phrase: "Because"

Phrase: "the fraction of white colonies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "in the two libraries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0023621:Libraries [Manufactured Object,Organization]
   827 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   827 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "not significantly different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the wild type residues at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "42"

Phrase: "contribute to aggregation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   790   C1880177:Contribute [Activity]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "to a similar extent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]
Processing 00000000.tx.182: Aggregation of Mutant Peptides in VitroWaldo et al. 

Phrase: "Aggregation of Mutant Peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "in VitroWaldo et al."
Processing 00000000.tx.183: (31) and Wurth et al. 

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "Wurth et al."
Processing 00000000.tx.184: (21) demonstrated the validity of GFP fusions as a screen for the aggregation behavior of proteins and peptides. 

Phrase: "(21"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "the validity of GFP fusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2349101:Validity [Quantitative Concept]

Phrase: "as a screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "for the aggregation behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.185: In particular, Wurth et al. 

Phrase: "In particular, Wurth et al."
Processing 00000000.tx.186: (21) showed that the fluorescence in vivo of a mutant of A42 fused to GFP correlated well with the solubility/aggregation behavior of the same mutant in the context of the 42-residue synthetic peptide. 

Phrase: "(21"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in vivo of a mutant of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "fused to GFP"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   838   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332583:Green [Qualitative Concept]
   760   C0699952:Fused [Functional Concept]
   726 E C1414861:FUSE [Gene or Genome]
   726 E C1708111:Fuse [Manufactured Object]

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "well with the solubility/aggregation behavior of the same mutant"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0004927:Behavior [Individual Behavior]
   739   C0037628:Solubility [Qualitative Concept]
   739   C0205170:Well [Qualitative Concept]
   739   C0332621:Aggregation [Functional Concept]
   739   C0439168:% aggregation [Quantitative Concept]
   739   C0445247:Same [Qualitative Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C2707008:Behavior [Clinical Attribute]
   739   C3146287:Well [Manufactured Object]

Phrase: "in the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of the 42-residue synthetic peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C1883254:synthetic [Activity]
Processing 00000000.tx.187: In the current study, however, because we have focused on residues at the C terminus of A42, it is reasonable to question whether GFP fusions can produce meaningful readouts for perturbations so close to the fusion linker and GFP. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "however,"

Phrase: "because"

Phrase: "we"

Phrase: "have"

Phrase: "focused on residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205234:Focused [Spatial Concept]
   790   C1285542:focused [Functional Concept]
   756   C1709915:Residue [Conceptual Entity]
   756   C1882936:RESIDUE [Phenomenon or Process]
   706 E C1609982:Residual [Qualitative Concept]

Phrase: "at the C terminus"

Phrase: "of A42,"

Phrase: "it"

Phrase: "is"

Phrase: "reasonable to"

Phrase: "question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "GFP fusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332466:fusions [Functional Concept]
   812   C1293131:fusions [Therapeutic or Preventive Procedure]
   733   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "can"

Phrase: "produce"

Phrase: "meaningful readouts for perturbations so"

Phrase: "close to the fusion linker"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332466:Fusion [Functional Concept]
   760   C0587267:Close [Functional Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GFP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   976   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.188: To address this question, we studied four sequences from our library as synthetic 42-residue peptides: Wild type A42, Asp41-Gln42, Leu41-Leu42, and Ser19-Pro34. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "four sequences from our library"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "as synthetic 42-residue peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   886   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "Wild type A42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "Asp41-Gln42,"

Phrase: "Leu41-Leu42,"

Phrase: "and"

Phrase: "Ser19-Pro34."
Processing 00000000.tx.189: The mutants Asp41-Gln42 and Leu41-Leu42 were chosen as representatives of the hydrophilic green mutants and the hydrophobic white mutants, respectively. 

Phrase: "The mutants Asp41-Gln42"

Phrase: "and"

Phrase: "Leu41-Leu42"

Phrase: "were"

Phrase: "chosen as representatives of the hydrophilic green mutants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0332583:Green [Qualitative Concept]
   744   C0475370:Hydrophilic [Qualitative Concept]
   744   C0596988:mutants [Cell or Molecular Dysfunction]
   744   C1707391:Chosen [Activity]
   711   C1882932:Representative [Activity]

Phrase: "and"

Phrase: "the hydrophobic white mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "respectively."
Processing 00000000.tx.190: The Ser19-Pro34 peptide is a control. 

Phrase: "The Ser19-Pro34 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "a control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.191: This non-C-terminal mutant was isolated previously by Wurth et al. 

Phrase: "This non-C-terminal mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "previously by Wurth et al."
Processing 00000000.tx.192: (21), who found the following: (i) as an A42-GFP fusion, Ser19-Pro34 was the most fluorescent mutant in their collection; 

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "the following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "(i"

Phrase: ")"

Phrase: "as an A42-GFP fusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "Ser19-Pro34"

Phrase: "was"

Phrase: "the most fluorescent mutant in their collection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.193: and (ii) as a synthetic 42-residue peptide, it was far more soluble and less prone to aggregate than wild type A42. 

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "as a synthetic 42-residue peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "it"

Phrase: "was"

Phrase: "far more soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "less prone to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033422:Prone [Spatial Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "aggregate than wild type A42."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0205418:Aggregate [Qualitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.194: The extent of aggregation was compared for the four peptides. 

Phrase: "The extent of aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "compared for the four peptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C0205450:Four [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.195: Peptide samples were prepared at 10 M concentration in 50 mM NaH2PO4, 100 mM NaCl, and 0.02% NaN3 (pH 7.3-7.4) and were incubated for 1 day at 30 C. 

Phrase: "Peptide samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared at 10 M concentration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086045:Concentration [Mental Process]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1446561:Concentration [Quantitative Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "in 50 mM NaH2PO4,"

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.02% NaN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074721:NaN3 [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(pH 7.3-7.4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C2678549:PH-4 [Gene or Genome]
   853   C0601906:PH 3 [Pharmacologic Substance]
   840   C1882074:pH 7 [Qualitative Concept]
   804   C0020283:[pH] [Quantitative Concept]
   804   C0450407:ph+ [Finding]
   804   C0450408:ph++ [Finding]
   804   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "incubated for 1 day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 30 C."
Processing 00000000.tx.196: After incubation, samples were centrifuged at 60,000 x g for 30 min to precipitate the aggregated material. 

Phrase: "After incubation,"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "centrifuged at 60,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 30 min to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456693:/30 min [Temporal Concept]
   901   C1442458:30 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "the aggregated material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]
Processing 00000000.tx.197: The amount of unaggregated peptide in the supernatant was then quantified by reverse phase HPLC (see "Materials and Methods"). 

Phrase: "The amount of unaggregated peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "quantified by reverse phase HPLC (see ""Materials"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0042789:see [Organism Function]
   748   C0205390:Phase [Temporal Concept]
   748   C0520510:Materials [Substance]
   748   C1555029:Reverse [Idea or Concept]
   748   C1947903:See [Activity]
   714   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.198: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.199: 2, the hydrophilic mutant, Asp41-Gln42, and the non-C-terminal green control, Ser19-Pro34, yielded substantial peaks at the elution time expected for monomers of each peptide. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "the hydrophilic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Asp41-Gln42,"

Phrase: "and"

Phrase: "the non-C-terminal green control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]

Phrase: "Ser19-Pro34,"

Phrase: "yielded"

Phrase: "substantial peaks at the elution time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0444505:peaks [Quantitative Concept]

Phrase: "expected for monomers of each peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0596973:monomers [Chemical Viewed Structurally]
   753   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.200: Integration of the peak areas indicated that for these two peptides almost the entire sample remained in solution and unaggregated. 

Phrase: "Integration of the peak areas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1158478:Integration [Genetic Function]
   760   C1705422:Integration [Machine Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that for these two peptides almost"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C0205448:Two [Quantitative Concept]

Phrase: "the entire sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "remained"

Phrase: "in solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "unaggregated."
Processing 00000000.tx.201: In contrast, wild type A42 and the hydrophobic mutant, Leu41-Leu42, showed almost no peaks corresponding to monomeric soluble peptide (Fig. 2). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "wild type A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "the hydrophobic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Leu41-Leu42,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "almost"

Phrase: "no peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaks [Quantitative Concept]

Phrase: "corresponding to monomeric soluble peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.202: These results confirm that the fluorescent phenotype of the GFP fusions in vivo is a reasonable predictor of the aggregation behavior of the isolated 42-residue peptides in vitro, even for mutants at the C terminus of the peptide. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the fluorescent phenotype of the GFP fusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031437:Phenotype [Organism Attribute]
   742   C1285572:Phenotype [Laboratory Procedure]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "is"

Phrase: "a reasonable predictor of the aggregation behavior"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2698872:Predictor [Idea or Concept]

Phrase: "of the isolated 42-residue peptides in vitro, even"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   818   C0021135:In Vitro [Intellectual Product]
   818   C1533691:in vitro [Qualitative Concept]
           vitro
   818   C2827718:In Vitro [Functional Concept]
   795   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   795   C0205409:Isolated [Functional Concept]
   795   C1548221:Isolated [Idea or Concept]
   795   C1709915:Residue [Conceptual Entity]
   795   C1882936:RESIDUE [Phenomenon or Process]
   724 E C0204727:Isolation [Therapeutic or Preventive Procedure]
   724 E C0220862:isolation [Laboratory Procedure]
   724 E C1609982:Residual [Qualitative Concept]

Phrase: "for mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "at the C terminus"

Phrase: "of the peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.203: Rate of AmyloidogenesisAlthough the experiments described above demonstrate that aggregation of A42 peptides in vitro mimics the phenotypes of the GFP fusions in vivo, it is important (i) to establish that the aggregated states of these peptides are indeed amyloid, and (ii) to compare the rates of amyloid formation for the different peptides. 

Phrase: "Rate of AmyloidogenesisAlthough"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0871208:Rate [Activity]
   790   C1521828:Rate [Quantitative Concept]

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "demonstrate"

Phrase: "that aggregation of A42 peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the phenotypes of the GFP fusions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0031437:Phenotypes [Organism Attribute]
   711 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "it"

Phrase: "is"

Phrase: "important (i) to"

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that"

Phrase: "the aggregated states of these peptides"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1301808:states [Geographic Area]
   719 E C1442792:State [Functional Concept]
   719 E C3148680:State [Geographic Area]

Phrase: "are"

Phrase: "indeed amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the rates of amyloid formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "for the different peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.204: View larger version (8K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(8K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.205: Thioflavin T fluorescence of wild type and mutant 42-residue peptides. 

Phrase: "Thioflavin T fluorescence of wild type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "mutant 42-residue peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.206: Synthetic peptides (20 M) were incubated in quiescent condition (not agitated). 

Phrase: "Synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "(20"

Phrase: "M)"

Phrase: "were"

Phrase: "incubated in quiescent condition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012634:condition [Disease or Syndrome]
   770   C0348080:Condition [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1705253:Condition [Conceptual Entity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "agitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitated [Sign or Symptom]

Phrase: ")."
Processing 00000000.tx.207: After 1 day of incubation samples were mixed with thioflavin T, and fluorescence was measured at 490 nm. 

Phrase: "After 1 day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1442449:1 Day [Temporal Concept]
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "of incubation samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "mixed with thioflavin T,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0205430:Mixed [Functional Concept]
   770   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured at 490 nm."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.208: Wild type A42 and Leu41-Leu42 showed thioflavin T fluorescence indicative of amyloid structure.  

Phrase: "Wild type A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "Leu41-Leu42"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "thioflavin T fluorescence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "indicative of amyloid structure."
Processing 00000000.tx.209: The presence of amyloid fibrils can be detected by monitoring the binding of dyes, such as Congo Red or thioflavin T (ThT). 

Phrase: "The presence of amyloid fibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "detected by monitoring"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0150369:Monitoring [Health Care Activity]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1516647:monitoring [Research Activity]

Phrase: "the binding of dyes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "such as Congo Red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009742:Congo Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0009738:Congo [Geographic Area]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "or"

Phrase: "thioflavin T (ThT)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.210: These dyes are known to bind specifically to the cross--structure in a variety of amyloids including those formed by insulin, transthyretin, polyglycine, apoAII, and A; 

Phrase: "These dyes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013343:Dyes [Indicator, Reagent, or Diagnostic Aid]
  1000   C2757062:Dyes [Molecular Function]
  1000   C2911146:Dyes NOS [Finding]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "specifically to the cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2828360:Cross [Conceptual Entity]

Phrase: "--"

Phrase: "structure in a variety of amyloids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those"

Phrase: "formed by insulin,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0205431:Formed [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]
   756 E C1522492:Form [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "transthyretin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: "polyglycine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071583:polyglycine [Amino Acid, Peptide, or Protein]

Phrase: "apoAII,"

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.211: yet they do not bind to monomeric or small oligomeric complexes of these peptides and proteins (40-43). 

Phrase: "yet"

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to monomeric"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   718   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "small oligomeric complexes of these peptides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1704241:Complexes [Chemical Viewed Structurally]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(40-43"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.212: Thioflavin T binding is easily monitored by the shift in fluorescence from 430 to 493 nm. 

Phrase: "Thioflavin T binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "monitored by the shift"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0333051:Shift [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "in fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "from 430"

Phrase: "to 493 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.213: View larger version (11K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.214: Kinetics of amyloid formation followed by thioflavin T fluorescence. 

Phrase: "Kinetics of amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022702:Kinetics [Natural Phenomenon or Process]
   770   C0220865:kinetics [Functional Concept]
   770   C2825046:Kinetics [Occupation or Discipline]

Phrase: "followed by thioflavin T fluorescence."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.215: Purified peptides (20 M) were agitated at 30 C. 

Phrase: "Purified peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(20"

Phrase: "M)"

Phrase: "were"

Phrase: "agitated at 30 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085631:Agitated [Sign or Symptom]
Processing 00000000.tx.216: Aliquots were removed every 30 min and mixed with thioflavin T, and fluorescence was measured at 490 nm. 

Phrase: "Aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "every 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "mixed with thioflavin T,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0205430:Mixed [Functional Concept]
   770   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured at 490 nm."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.217: Wild type A42 and the hydrophobic mutant, Leu41-Leu42 form amyloid from the outset, whereas the hydrophilic mutant, Asp41-Gln42, like A40, aggregates only after a 90-120-min lag. 

Phrase: "Wild type A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "the hydrophobic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Leu41-Leu42 form amyloid from the outset,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whereas"

Phrase: "the hydrophilic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Asp41-Gln42,"

Phrase: "like A40,"

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "only after a 90-120-min lag."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205171:Only [Quantitative Concept]
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1416797:Lag [Gene or Genome]
   748   C1720467:Only [Intellectual Product]
Processing 00000000.tx.218: The control peptide, Ser19-Pro34, showed little or no ThT binding even after 5 h.  

Phrase: "The control peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "Ser19-Pro34,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no ThT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "even after 5 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.219: To assess binding to thioflavin T, each of the synthetic peptides (20 M) was incubated for 1 day without agitation, and samples were then mixed with ThT, and fluorescence was measured at 490 nm. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "binding to thioflavin T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "each of the synthetic peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C1457900:Each [Quantitative Concept]
   760   C1883254:synthetic [Activity]

Phrase: "(20"

Phrase: "M)"

Phrase: "was"

Phrase: "incubated for 1 day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "without agitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitation [Sign or Symptom]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "mixed with ThT,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0205430:Mixed [Functional Concept]
   770   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "measured at 490 nm."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.220: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.221: 3, the hydrophobic mutant Leu41-Leu42 bound ThT to an extent similar to wild type A42. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "the hydrophobic mutant Leu41-Leu42"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "ThT to an extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "similar to wild type A42."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.222: In contrast, the hydrophilic mutant, Asp41-Gln42, and the soluble control, Ser19-Pro34, showed poor ThT binding. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the hydrophilic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Asp41-Gln42,"

Phrase: "and"

Phrase: "the soluble control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "Ser19-Pro34,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "poor ThT binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.223: Thus, wild type A42 and Leu41-Leu42 readily form amyloid fibrils, whereas Asp41-Gln42 and Ser19-Pro34 do so only poorly. 

Phrase: "Thus,"

Phrase: "wild type A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "Leu41-Leu42 readily"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "whereas"

Phrase: "Asp41-Gln42"

Phrase: "and"

Phrase: "Ser19-Pro34"

Phrase: "do"

Phrase: "so only poorly."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0037640:SO [Geographic Area]
   827   C0205169:Poorly [Qualitative Concept]
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]
Processing 00000000.tx.224: Next, we followed the rate of fibril formation under conditions that favor aggregation: agitation, rather than quiescent incubation. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the rate of fibril formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "that favor aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: ":"

Phrase: "agitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitation [Sign or Symptom]

Phrase: "rather than"

Phrase: "quiescent incubation."
Processing 00000000.tx.225: Time course measurements of ThT binding showed that wild type A42 and the hydrophobic mutant, Leu41-Leu42, began to form amyloid within a few minutes. 

Phrase: "Time course measurements of ThT binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1254545:time measurements [Laboratory Procedure]
   748   C0242485:measurements [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that wild type A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "the hydrophobic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Leu41-Leu42,"

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid within a few minutes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.226: In contrast, the hydrophilic mutant, Asp41-Gln42, like A40, began to form amyloid only during the 2nd h of incubation (Fig. 4). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the hydrophilic mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Asp41-Gln42,"

Phrase: "like A40,"

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid only during the 2nd h of incubation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.227: (The control peptide, Ser19-Pro34, showed little or no ThT binding even after 5 h.) 

Phrase: "("

Phrase: "The control peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "Ser19-Pro34,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no ThT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "even after 5 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: ")"
Processing 00000000.tx.228: Thus, the behavior of the synthetic 42-residue peptides in vitro validates the results observed for the GFP fusions in vivo. 

Phrase: "Thus,"

Phrase: "the behavior of the synthetic 42-residue peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0004927:Behavior [Individual Behavior]
   744   C2707008:Behavior [Clinical Attribute]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "validates"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "observed for the GFP fusions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   757   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332466:fusions [Functional Concept]
   748   C0332583:Green [Qualitative Concept]
   748   C1293131:fusions [Therapeutic or Preventive Procedure]
   748   C1441672:Observed [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.229: Hydrophobic mutants at positions 41 and 42 mimic wild type behavior, whereas hydrophilic mutants retard amyloidogenesis. 

Phrase: "Hydrophobic mutants at positions 41"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "42"

Phrase: "mimic"

Phrase: "wild type behavior,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0004927:Behavior [Individual Behavior]
   827   C2707008:Behavior [Clinical Attribute]
   755 E C2986890:Behavioral [Idea or Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "whereas"

Phrase: "hydrophilic mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "retard"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:retard [Qualitative Concept]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0237477:Arrest [Temporal Concept]
   916 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "amyloidogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706803:Amyloidogenesis [Cell or Molecular Dysfunction]
Processing 00000000.tx.230: View larger version (16K): [in this window] [in a new window]  FIGURE 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 5."
Processing 00000000.tx.231: Correlation of the fluorescence in vivo of A42-GFP fusions (except Gly and Pro) with biophysical properties of the residues at positions 41 and 42. 

Phrase: "Correlation of the fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "in vivo of A42-GFP fusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "("

Phrase: "except Gly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Pro) with biophysical properties of the residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C2987124:PRO [Intellectual Product]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42."
Processing 00000000.tx.232: A, correlation with the sum of hydrophobicities at positions 41 and 42. 

Phrase: "A,"

Phrase: "correlation with the sum of hydrophobicities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42."
Processing 00000000.tx.233: B, correlation with the sum of -sheet propensities at positions 41 and 42. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "correlation with the sum of -sheet propensities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42."
Processing 00000000.tx.234: C, correlation with the aggregation propensity predicted by the equation of Chiti et al. 

Phrase: "C,"

Phrase: "correlation with the aggregation propensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "predicted by the equation of Chiti et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0552449:Equation [Conceptual Entity]
   744   C0681842:Predicted [Idea or Concept]
   744   C1882327:%{Predicted} [Quantitative Concept]
Processing 00000000.tx.235: (26).   

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.236: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  A40 is the primary product of the proteolytic cleavage of the Alzheimer amyloid precursor protein. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A40"

Phrase: "is"

Phrase: "the primary product of the proteolytic cleavage of the Alzheimer amyloid precursor protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C1514468:product [Entity]
   735   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.237: Yet senile plaques are composed primarily of A42 (5, 14-16). 

Phrase: "Yet senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   827   C0392079:Senile [Finding]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   771 E C0231337:Old age [Finding]
   771 E C1999167:Old age [Population Group]

Phrase: "are"

Phrase: "composed"

Phrase: "primarily of A42"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "14-16"

Phrase: ")."
Processing 00000000.tx.238: Moreover, studies in vitro have demonstrated that A42 has a far higher propensity to aggregate than A40 (5, 15, 17, 44). 

Phrase: "Moreover,"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that A42"

Phrase: "has"

Phrase: "a far higher propensity to"

Phrase: "aggregate than A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205418:Aggregate [Qualitative Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15,"

Phrase: "17,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.239: In the current studies we sought to elucidate which features of the C-terminal residues are responsible for the greater amyloidogenicity of the longer peptide. 

Phrase: "In the current studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "which"

Phrase: "features of the C-terminal residues"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C1521970:Feature [Qualitative Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "responsible for the greater amyloidogenicity of the longer peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]
Processing 00000000.tx.240: The Role of HydrophobicityFig. 

Phrase: "The Role of HydrophobicityFig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.241: 1A shows that mutants with hydrophobic residues at both positions 41 and 42 have high propensities to aggregate. 

Phrase: "1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that mutants with hydrophobic residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "at both"

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "41"

Phrase: "and"

Phrase: "42"

Phrase: "have"

Phrase: "high propensities to"

Phrase: "aggregate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.242: Some of these hydrophobic mutants, such as Val41-Ile42 and Leu41-Ile42, are even more prone to aggregate than the wild type (Ile41-Ala42) sequence. 

Phrase: "Some of these hydrophobic mutants,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205392:Some [Quantitative Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C0598629:Hydrophobic [Qualitative Concept]
   760   C3540770:Some [Intellectual Product]

Phrase: "such as Val41-Ile42"

Phrase: "and"

Phrase: "Leu41-Ile42,"

Phrase: "are"

Phrase: "even more prone to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033422:Prone [Spatial Concept]

Phrase: "aggregate than the wild type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0205418:Aggregate [Qualitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "(Ile41-Ala42"

Phrase: ")"

Phrase: "sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.243: The greater hydrophobicity of Ile relative to Ala at position 42 presumably accounts for this enhanced aggregation. 

Phrase: "The greater hydrophobicity of Ile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0598629:Hydrophobicity [Qualitative Concept]

Phrase: "relative to Ala"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "at position 42 presumably"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0733755:Position [Spatial Concept]
   755 E C0240795:POSITIONAL [Finding]

Phrase: "accounts for this enhanced aggregation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
   760   C1551359:account [Idea or Concept]
   760   C2349975:Enhanced [Activity]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]
Processing 00000000.tx.244: Likewise, for the Val41-Ala42 mutant, the lower hydrophobicity of Val relative to Ile at position 41 may account for the slightly decreased aggregation of this mutant relative to wild type. 

Phrase: "Likewise,"

Phrase: "for the Val41-Ala42 mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "the lower hydrophobicity of Val"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0598629:Hydrophobicity [Qualitative Concept]

Phrase: "relative to Ile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "at position 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "may"

Phrase: "account for the slightly decreased aggregation of this mutant relative"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   739   C0080103:Relative [Family Group]
   739   C0205216:Decreased [Quantitative Concept]
   739   C0205345:Relative [Qualitative Concept]
   739   C0332621:Aggregation [Functional Concept]
   739   C0392756:Decreased [Qualitative Concept]
   739   C0439168:% aggregation [Quantitative Concept]
   739   C0442797:decreased [Qualitative Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C0750482:Slightly [Idea or Concept]
   739   C1547039:*Relative [Quantitative Concept]
   739   C1551359:account [Idea or Concept]
   739   C2741673:Account # [Clinical Attribute]
   739   C2981730:Account [Classification]
   706 E C0547047:Decrease [Quantitative Concept]

Phrase: "to wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.245: Mutants that have one hydrophilic and one hydrophobic residue at the C terminus (e.g. Lys41-Leu42, Gln41-Leu42, and Glu41-Leu42) are slightly less prone to aggregate than the double hydrophobic sequences, whereas mutants that have two polar residues at the C terminus (e.g. Asp41-Glu42, Asp41-Gln42, and His41-Asn42) are the least aggregating sequences in the library. 

Phrase: "Mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "have"

Phrase: "one hydrophilic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475370:Hydrophilic [Qualitative Concept]

Phrase: "and"

Phrase: "one hydrophobic residue at the C terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "("

Phrase: "e.g. Lys41-Leu42,"

Phrase: "Gln41-Leu42,"

Phrase: "and"

Phrase: "Glu41-Leu42"

Phrase: ")"

Phrase: "are"

Phrase: "slightly less prone to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033422:Prone [Spatial Concept]
   812   C0750482:Slightly [Idea or Concept]

Phrase: "aggregate than the double hydrophobic sequences,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C0205173:Double [Functional Concept]
   753   C0205418:Aggregate [Qualitative Concept]
   753   C0598629:Hydrophobic [Qualitative Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "whereas"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "have"

Phrase: "two polar residues at the C terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "("

Phrase: "e.g. Asp41-Glu42,"

Phrase: "Asp41-Gln42,"

Phrase: "and"

Phrase: "His41-Asn42"

Phrase: ")"

Phrase: "are"

Phrase: "the least aggregating sequences in the library."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0162326:Sequences [Nucleotide Sequence]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.246: These results indicate that the hydrophobicity of residues at positions 41 and 42 is a major contributor to the enhanced amyloidogenicity of A42 relative to A40, and would be consistent with residues Ile41 and Ala42 occurring in the buried core of A fibrils.3 -Sheet PropensityAlthough the hydrophobicity of residues at positions 41 and 42 clearly plays a dominant role in promoting aggregation, hydrophobicity alone does not explain the properties of all mutants in our collections. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the hydrophobicity of residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0598629:Hydrophobicity [Qualitative Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42"

Phrase: "is"

Phrase: "a major contributor to the enhanced amyloidogenicity of A42"

Phrase: "relative to A40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "would"

Phrase: "be"

Phrase: "consistent with residues Ile41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "Ala42"

Phrase: "occurring in the buried core of A fibrils.3 -Sheet PropensityAlthough"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   756   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0225328:fibrils [Cell Component]
   738   C0444669:Core [Spatial Concept]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1167518:core [Cell Component]
   738   C1706352:Core [Medical Device]
   738   C1882467:Core [Manufactured Object]
   738   C2349187:Sheet [Quantitative Concept]
   738   C3274653:Core [Body Substance]
   704   C1709305:Occur [Activity]
   704 E C1948066:Fibril [Physical Object]
   704   C2745955:OCCUR [Temporal Concept]

Phrase: "the hydrophobicity of residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0598629:Hydrophobicity [Qualitative Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42 clearly"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a dominant role in promoting aggregation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "hydrophobicity"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobicity [Qualitative Concept]
   907 E C0034494:Rabies [Disease or Syndrome]
   907 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   900 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "the properties of all mutants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "in our collections."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0600644:Collections [Intellectual Product]
  1000   C1516698:Collection [Functional Concept]
  1000   C1704814:Collection [Idea or Concept]
   916 E C1516695:Collected [Idea or Concept]
Processing 00000000.tx.247: For example, four libraries of mutants were constructed in which only position 41 or 42 was randomized, whereas the other position was constrained to be either proline or glycine (TABLE TWO). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "four libraries of mutants"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0023621:Libraries [Manufactured Object,Organization]
   737 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   737 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "constructed in which only position 41"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205171:Only [Quantitative Concept]
   753   C0733755:Position [Spatial Concept]
   753   C1720467:Only [Intellectual Product]
   719   C2827421:Construct [Classification]

Phrase: "or"

Phrase: "42"

Phrase: "was"

Phrase: "randomized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034656:randomized [Research Activity]

Phrase: ","

Phrase: "whereas"

Phrase: "the other position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "was"

Phrase: "constrained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707494:Constrained [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "either proline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: "(TABLE TWO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.248: For all four of these libraries, the vast majority (90%) of mutants yielded green fluorescent (i.e. less aggregating) GFP fusions (TABLE TWO), and the few white colonies that were observed did not express the fusions protein (presumably because of the presence of stop codons). 

Phrase: "For all four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "of these libraries,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0023621:Libraries [Manufactured Object,Organization]
   966 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   966 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the vast majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680220:majority [Social Behavior]

Phrase: "(90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "of mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "yielded"

Phrase: "green fluorescent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(i.e. less"

Phrase: "aggregating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregating [Qualitative Concept]

Phrase: ")"

Phrase: "GFP fusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332466:fusions [Functional Concept]
   812   C1293131:fusions [Therapeutic or Preventive Procedure]
   733   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(TABLE TWO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205448:Two [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the few white colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "that"

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "the fusions protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(presumably because of the presence of stop codons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0242611:Stop Codon [Nucleotide Sequence]
   744   C0009221:Codon [Nucleotide Sequence]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1095825:Codon [Plant]
   744   C1947925:Stop [Activity]
   744   C2746065:Stop [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.249: These results suggest that all (or nearly all) sequences with proline or glycine at positions 41 or 42 have significantly reduced propensities to aggregate. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "all ("

Phrase: "or"

Phrase: "nearly"

Phrase: "all)"

Phrase: "sequences with proline"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0004793:Sequence [Nucleotide Sequence]
   790   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0162326:Sequence [Nucleotide Sequence]
   790   C0162327:Sequence [Nucleotide Sequence]
   790   C1519249:Sequence [Functional Concept]

Phrase: "or"

Phrase: "glycine at positions 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0522461:Glycine [Plant]

Phrase: "or"

Phrase: "42"

Phrase: "have"

Phrase: "significantly reduced propensities to"

Phrase: "aggregate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.250: This behavior was observed despite the fact that proline is a hydrophobic residue, and glycine is neither polar nor non-polar. 

Phrase: "This behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "was"

Phrase: "observed despite the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "that proline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a hydrophobic residue,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: "is"

Phrase: "neither polar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813983:polar [Quantitative Concept]

Phrase: "nor"

Phrase: "non-polar."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0813983:polar [Quantitative Concept]
   861   C1518422:Non [Functional Concept]
Processing 00000000.tx.251: Proline and glycine are known to be -sheet breakers (39), and their occurrence at positions 41 or 42 presumably interferes with the formation of cross- amyloid structure. 

Phrase: "Proline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be -"

Phrase: "sheet breakers"

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "their occurrence at positions 41"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "or"

Phrase: "42 presumably"

Phrase: "interferes with the formation of cross- amyloid structure."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   793   C3544411:amyloid structure formation [Molecular Function]
   770   C0521102:Interferes with [Qualitative Concept]
           Interfere
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0678594:Structure [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
   744   C2828360:Cross [Conceptual Entity]
Processing 00000000.tx.252: The wild type residues, Ile41 and Ala42, are both hydrophobic and good -sheet formers. 

Phrase: "The wild type residues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "Ile41"

Phrase: "and"

Phrase: "Ala42,"

Phrase: "are"

Phrase: "both hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "and"

Phrase: "good -sheet formers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205156:Former [Temporal Concept]
   827   C0750523:FORMER [Idea or Concept]
Processing 00000000.tx.253: In A42, these residues, together with residues Val39 and Val40 (which are also hydrophobic -sheet formers), may form a -strand at an early stage of aggregation, and thereby lower the kinetic barrier for the aggregation of A42 relative to A40. 

Phrase: "In A42,"

Phrase: "these residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "together with residues Val39"

Phrase: "and"

Phrase: "Val40"

Phrase: "("

Phrase: "which"

Phrase: "are"

Phrase: "also hydrophobic -sheet formers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205156:Former [Temporal Concept]
   812   C0750523:FORMER [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a -strand at an early stage of aggregation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1704972:Strand [Spatial Concept]
   744   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "thereby"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the kinetic barrier for the aggregation of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1706912:BARRIER [Medical Device]
   743   C1563056:Motion barrier [Finding]

Phrase: "relative to A40."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.254: Tertiary InteractionsAlthough hydrophobicity and -sheet propensity account for most of the observations reported here, two of the mutants shown in Fig. 

Phrase: "Tertiary InteractionsAlthough hydrophobicity"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0598629:Hydrophobicity [Qualitative Concept]
   734 E C0034494:Rabies [Disease or Syndrome]
   734 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   727 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "and -"

Phrase: "sheet propensity account for most of the observations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1551359:account [Idea or Concept]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here,"

Phrase: "two of the mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205448:Two [Quantitative Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.255: 1, Ile41-Arg42 and Arg41-Arg42, yield less fluorescent (i.e. more aggregating) GFP fusions than would be expected for sequences containing arginine, which is an extremely polar residue (24). 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "Ile41-Arg42"

Phrase: "and"

Phrase: "Arg41-Arg42,"

Phrase: "yield"

Phrase: "less fluorescent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(i.e. more"

Phrase: "aggregating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregating [Qualitative Concept]

Phrase: ")"

Phrase: "GFP fusions than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0332466:fusions [Functional Concept]
   760   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "be"

Phrase: "expected for sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0162326:Sequences [Nucleotide Sequence]
   790   C1517001:Expected [Idea or Concept]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "arginine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "an extremely polar residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.256: The behavior of these mutants might be explained by the structure of A fibrils modeled by Tycko and co-workers (45) from solid-state NMR experiments. 

Phrase: "The behavior of these mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0004927:Behavior [Individual Behavior]
   760   C2707008:Behavior [Clinical Attribute]

Phrase: "might"

Phrase: "be"

Phrase: "explained by the structure of A fibrils"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0225328:fibrils [Cell Component]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0678594:Structure [Spatial Concept]
   714 E C1948066:Fibril [Physical Object]

Phrase: "modeled by Tycko"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(45"

Phrase: ")"

Phrase: "from solid-state NMR experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.257: In that structure, A forms a hairpin, which would place the C-terminal amino acids in close proximity to glutamic acid at position 11. 

Phrase: "In"

Phrase: "that structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a hairpin,"

Phrase: "which"

Phrase: "would"

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "the C-terminal amino acids in close proximity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   816   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "to glutamic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523665:Glutamic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "at position 11."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.258: Interaction between the positively charged arginine and the negatively charged glutamic acid might compensate for burying the charged arginine side chain. 

Phrase: "Interaction between the positively charged arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the negatively"

Phrase: "charged"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]
   966 E C0007961:Charge [Quantitative Concept]

Phrase: "glutamic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523665:Glutamic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "might"

Phrase: "compensate for burying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205432:compensate [Qualitative Concept]

Phrase: "the charged arginine side chain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0337112:Chain [Manufactured Object]
   812   C0441987:Side [Spatial Concept]
   812   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.259: This interpretation would suggest that a sequence with lysines at positions 41 and 42 might also yield less fluorescent (more aggregating) GFP fusions than expected for sequences containing charged residues at both positions. 

Phrase: "This interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a sequence with lysines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42"

Phrase: "might"

Phrase: "also"

Phrase: "yield"

Phrase: "less fluorescent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "aggregating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregating [Qualitative Concept]

Phrase: ")"

Phrase: "GFP fusions than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0332466:fusions [Functional Concept]
   760   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "expected for sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0162326:Sequences [Nucleotide Sequence]
   790   C1517001:Expected [Idea or Concept]
   756 E C0004793:Sequence [Nucleotide Sequence]
   756 E C0162327:Sequence [Nucleotide Sequence]
   756 E C1519249:Sequence [Functional Concept]
   706 E C1548958:Sequential [Idea or Concept]
   706 E C1705294:Sequential [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "charged residues at both positions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.260: To test this expectation, we used site-directed mutagenesis to construct the Lys41-Lys42 mutant. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this expectation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679138:Expectation [Idea or Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "site-directed mutagenesis to"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   812   C0079866:Mutagenesis [Molecular Function]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
   812   C3146302:Mutagenesis [Laboratory Procedure]
   779   C0439851:Direct [Qualitative Concept]
   779   C1947931:Direct [Qualitative Concept]
   741 E C0439755:Directions [Spatial Concept]
   741 E C0449738:Direction [Spatial Concept]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "the Lys41-Lys42 mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.261: Fluorescence of the GFP fusion of this mutant, although not as diminished as the Arg41-Arg42 mutant, was indeed lower than expected for a doubly charged dipeptide. 

Phrase: "Fluorescence of the GFP fusion of this mutant,"

Phrase: "although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "as"

Phrase: "diminished as the Arg41-Arg42 mutant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205216:Diminished [Quantitative Concept]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "indeed lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "expected for a doubly charged dipeptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0012512:Dipeptide [Amino Acid, Peptide, or Protein]
   753   C1517001:Expected [Idea or Concept]
   753   C1706211:Charged [Organism Attribute]
Processing 00000000.tx.262: (Its fluorescence was approximately midway between those of Asp41-Glu42 and Arg41-Arg42; data not shown). 

Phrase: "("

Phrase: "Its fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "approximately midway between those of Asp41-Glu42"

Phrase: "and"

Phrase: "Arg41-Arg42"

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.263: Correlation of Aggregation with Hydrophobicity, -Sheet Propensity, and Previous ModelsTo verify the importance of hydrophobicity and -sheet propensity at positions 41 and 42, we plotted the fluorescence of A42-GFP fusions against each of these parameters. 

Phrase: "Correlation of Aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlation [Qualitative Concept]

Phrase: "with Hydrophobicity, -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobicity [Qualitative Concept]
   907 E C0034494:Rabies [Disease or Syndrome]
   907 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   900 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "Sheet Propensity,"

Phrase: "and"

Phrase: "Previous ModelsTo"

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the importance of hydrophobicity"

Phrase: "and -"

Phrase: "sheet propensity at positions 41"

Phrase: "and"

Phrase: "42,"

Phrase: "we"

Phrase: "plotted"

Phrase: "the fluorescence of A42-GFP fusions"

Phrase: "against each"

Phrase: "of these parameters."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]
Processing 00000000.tx.264: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.265: 5A, the fluorescence of our mutants and the sum of hydrophobicities at positions 41 and 42 exhibit a strong negative correlation (R = 0.83). 

Phrase: "5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: "the fluorescence of our mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the sum of hydrophobicities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515051:Sum [Quantitative Concept]

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a strong negative correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]

Phrase: "(R = 0.83"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.266: Thus, sequences having hydrophobic residues at these positions have higher propensities to aggregate. 

Phrase: "Thus,"

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "having"

Phrase: "hydrophobic residues at these positions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "have"

Phrase: "higher propensities to"

Phrase: "aggregate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.267: Fluorescence of the A42-GFP fusions was also plotted against the sum of the -sheet propensities (25) at positions 41 and 42. 

Phrase: "Fluorescence of the A42-GFP fusions"

Phrase: "was"

Phrase: "also"

Phrase: "plotted against the sum of the -sheet propensities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1515051:Sum [Quantitative Concept]
   744   C2349187:Sheet [Quantitative Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "at positions 41"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "42."
Processing 00000000.tx.268: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.269: 5B, this plot also showed a strong negative correlation (R = 0.85), thereby supporting the hypothesis that -sheet propensity at these positions favors aggregation. 

Phrase: "5B,"

Phrase: "this plot also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a strong negative correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]

Phrase: "(R = 0.85"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that -sheet propensity at these positions"

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.270: Chiti et al. 

Phrase: "Chiti et al."
Processing 00000000.tx.271: (26) showed that rates of aggregation could be predicted from intrinsic factors including hydrophobicity, -sheet propensity, -helical propensity, and charge. 

Phrase: "(26"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that rates of aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "predicted from intrinsic factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021918:intrinsic factors [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0205102:Intrinsic [Spatial Concept]
   770   C0439674:Intrinsic [Functional Concept]
   770   C0681842:Predicted [Idea or Concept]
   770   C1882327:%{Predicted} [Quantitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "hydrophobicity, -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobicity [Qualitative Concept]
   907 E C0034494:Rabies [Disease or Syndrome]
   907 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   900 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "sheet propensity, -"

Phrase: "helical propensity,"

Phrase: "and"

Phrase: "charge."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007961:Charge [Quantitative Concept]
  1000   C1706211:Charge [Organism Attribute]
Processing 00000000.tx.272: They derived an equation to quantify this prediction (see Equation 1 under "Materials and Methods"). 

Phrase: "They"

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "an equation to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0552449:Equation [Conceptual Entity]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "this prediction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:Prediction [Idea or Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Equation 1 under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520510:Materials [Substance]
   770   C0552449:Equation [Conceptual Entity]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.273: For our collections of mutants in residues 41 and 42, we plotted the observed fluorescence of the A42-GFP fusions against the aggregation rate predicted by Equation 1 (Fig. 5C). 

Phrase: "For our collections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0600644:Collections [Intellectual Product]
  1000   C1516698:Collection [Functional Concept]
  1000   C1704814:Collection [Idea or Concept]
   916 E C1516695:Collected [Idea or Concept]

Phrase: "of mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "in residues 41"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "42,"

Phrase: "we"

Phrase: "plotted"

Phrase: "the observed fluorescence of the A42-GFP fusions"

Phrase: "against the aggregation rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "predicted by Equation 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0552449:Equation [Conceptual Entity]
   770   C0681842:Predicted [Idea or Concept]
   770   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.274: The observed fluorescence and the aggregation predicted by this equation, which includes both hydrophobicity and -sheet propensity, showed a better correlation (R = 0.911) than either hydrophobicity alone (Fig. 5A) or -sheet propensity alone (Fig. 5B). 

Phrase: "The observed fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "the aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "predicted by this equation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0552449:Equation [Conceptual Entity]
   770   C0681842:Predicted [Idea or Concept]
   770   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "both hydrophobicity"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobicity [Qualitative Concept]
   907 E C0034494:Rabies [Disease or Syndrome]
   907 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   900 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "and -"

Phrase: "sheet propensity,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a better correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "(R = 0.911"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "than either hydrophobicity"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0598629:Hydrophobicity [Qualitative Concept]
   768 E C0034494:Rabies [Disease or Syndrome]
   768 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   761 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "or -sheet propensity"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.275: The Arg41-Arg42 mutant deviated significantly from the trend (Fig. 5C). 

Phrase: "The Arg41-Arg42 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "deviated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012727:Deviated [Spatial Concept]

Phrase: "significantly from the trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521798:trend [Temporal Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.276: As described above, the behavior of this sequence may be explained by attractive electrostatic interactions between the arginine side chain and glutamic acid at position 11. 

Phrase: "As"

Phrase: "described above,"

Phrase: "the behavior of this sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0004927:Behavior [Individual Behavior]
   760   C2707008:Behavior [Clinical Attribute]

Phrase: "may"

Phrase: "be"

Phrase: "explained by attractive electrostatic interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0376534:electrostatic [Natural Phenomenon or Process]
   760   C2346874:Attractive [Qualitative Concept]
   726   C1704675:Interaction [Functional Concept]

Phrase: "between the arginine side chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0337112:Chain [Manufactured Object]
   827   C0441987:Side [Spatial Concept]
   827   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "glutamic acid at position 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C0523665:Glutamic Acid [Laboratory Procedure]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.277: Sequence Determinants of the Enhanced Amyloidogenicity of A42 Relative to A40Although both A40 and A42 assemble into amyloid fibrils, the longer peptide aggregates more readily both in vitro and in vivo (17, 29, 44). 

Phrase: "Sequence Determinants of the Enhanced Amyloidogenicity of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1521761:Determinant [Functional Concept]

Phrase: "Relative to A40Although"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "both A40"

Phrase: "and"

Phrase: "A42"

Phrase: "assemble into amyloid fibrils,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0225328:fibrils [Cell Component]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1706853:Assemble [Activity]
   737 E C1948066:Fibril [Physical Object]

Phrase: "the longer peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "more readily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(17,"

Phrase: "29,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.278: Although it might have been hypothesized that length per se is sufficient to increase the amyloidogenicity of A, this hypothesis is disproved by our results. 

Phrase: "Although"

Phrase: "it"

Phrase: "might"

Phrase: "have"

Phrase: "been"

Phrase: "hypothesized"

Phrase: "that length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "per se"

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the amyloidogenicity of A,"

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "disproved by our results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.279: In particular, fluorescence studies of A42-GFP fusions containing polar amino acids at positions 41 and 42 demonstrate that these sequences are in fact less prone to aggregate than the null mutant, A40, which has both residues deleted entirely (Fig. 1). 

Phrase: "In particular, fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "studies of A42-GFP fusions"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   757   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332466:fusions [Functional Concept]
   748   C0332583:Green [Qualitative Concept]
   748   C0557651:Study [Manufactured Object]
   748   C0947630:studies [Laboratory Procedure]
   748   C1293131:fusions [Therapeutic or Preventive Procedure]
   748   C2603343:Study [Research Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "polar amino acids at positions 41"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0815038:polar amino acids [Amino Acid, Peptide, or Protein]
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "42"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "these sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "are in fact less prone to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033422:Prone [Spatial Concept]
   753   C1551058:Are [Quantitative Concept]

Phrase: "aggregate than the null mutant,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205418:Aggregate [Qualitative Concept]
   760   C0456148:Null [Quantitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "A40,"

Phrase: "which"

Phrase: "has"

Phrase: "both residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "entirely"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.280: Our experiments using several libraries of A42-GFP fusions as well as synthetic 42 residue peptides demonstrate that rather than length, it is the hydrophobicity and -sheet propensity of residues 41 and 42 that cause the enhanced amyloidogenicity of A42 relative to A40.  

Phrase: "Our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "several libraries of A42-GFP fusions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0023621:Libraries [Manufactured Object,Organization]
   711 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   711 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as well as"

Phrase: "synthetic 42 residue peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   886   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "rather than"

Phrase: "length,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "the hydrophobicity"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobicity [Qualitative Concept]
   907 E C0034494:Rabies [Disease or Syndrome]
   907 E C0034496:rabies, NOS [Immunologic Factor,Organic Chemical,Pharmacologic Substance]
   900 E C1609481:Hydrophobia [Mental or Behavioral Dysfunction]

Phrase: "and -"

Phrase: "sheet propensity of residues 41"

Phrase: "and"

Phrase: "42"

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the enhanced amyloidogenicity of A42"

Phrase: "relative to A40."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.281: FOOTNOTES  * The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.282: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.283: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.284: 1 To whom correspondence should be addressed. 

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.285: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.286: 609-258-2901; 

Phrase: "609-258-2901"

Phrase: ";"
Processing 00000000.tx.287: Fax: 609-258-6746; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "609-258-6746"

Phrase: ";"
Processing 00000000.tx.288: E-mail: hecht{at}princeton.edu . 2 The abbreviations used are: A, amyloid ; GFP, green fluorescent protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "hecht{at}princeton.edu . 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   804   C0331889:Princeton [Health Care Related Organization]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A,"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; GFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   976   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.289: HFIP, hexafluoroisopropanol; 

Phrase: "HFIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062622:hexafluoroisopropanol [Organic Chemical]

Phrase: "hexafluoroisopropanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062622:hexafluoroisopropanol [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.290: HPLC, high pressure liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high pressure liquid chromatography"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0460139:Pressure [Finding]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1306345:Pressure [Functional Concept]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.291: ThT, thioflavin T. 

Phrase: "ThT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "thioflavin T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.292: 3 R. 

Phrase: "3 R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.293: Tykco, personal communication.  

Phrase: "Tykco,"

Phrase: "personal communication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]
Processing 00000000.tx.294: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Koo, E. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.295: H., Lansbury, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.296: T., Jr., and Kelly, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Kelly,"

Phrase: "J."
Processing 00000000.tx.297: W. 

Phrase: "W."
Processing 00000000.tx.298: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.299: Natl. 

Phrase: "Natl."
Processing 00000000.tx.300: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.301: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.302: U. 

Phrase: "U."
Processing 00000000.tx.303: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.304: A. 

Phrase: "A."
Processing 00000000.tx.305: 96, 9989-9990[Free FullText] Carrell, R. 

Phrase: "96,"

Phrase: "9989-9990"

Phrase: "[Free FullText"

Phrase: "] Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.306: W., and Lomas, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.307: A. 

Phrase: "A."
Processing 00000000.tx.308: (1997) Lancet 350, 134-138[CrossRef][Medline] [OrderarticleviaInfotrieve] Thomas, P. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Lancet 350,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "134-138"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Thomas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.309: J., Qu, B., and Pedersen, P. 

Phrase: "J.,"

Phrase: "Qu,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Pedersen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.310: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.311: (1995) Trends Biochem. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.312: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.313: 20, 456-459[CrossRef][Medline] [OrderarticleviaInfotrieve] Slipe, J. 

Phrase: "20,"

Phrase: "456-459"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Slipe,"

Phrase: "J."
Processing 00000000.tx.314: D. 

Phrase: "D."
Processing 00000000.tx.315: (1992) Annu. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.316: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.317: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.318: 61, 947-975[CrossRef][Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "61,"

Phrase: "947-975"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.319: (2001) Physiol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Physiol."
Processing 00000000.tx.320: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.321: 81, 741-766[Abstract/Free FullText] Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. 

Phrase: "81,"

Phrase: "741-766"

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.322: D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W.,"

Phrase: "Larson,"

Phrase: "E.,"

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Viitanen,"

Phrase: "M."

Phrase: ","

Phrase: "Peskind,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.323: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.324: Med. 

Phrase: "Med."
Processing 00000000.tx.325: 2, 864-870[CrossRef][Medline] [OrderarticleviaInfotrieve] Weggen, S., Eriksen, J. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864-870"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Weggen,"

Phrase: "S."

Phrase: ","

Phrase: "Eriksen,"

Phrase: "J."
Processing 00000000.tx.326: L., Das, P., Sagi, S. 

Phrase: "L., Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   861   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sagi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.327: A., Wang, R., Pietrzik, C. 

Phrase: "A.,"

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Pietrzik,"

Phrase: "C."
Processing 00000000.tx.328: U., Findlay, K. 

Phrase: "U.,"

Phrase: "Findlay,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.329: A., Smith, T. 

Phrase: "A.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.330: E., Murphy, M. 

Phrase: "E.,"

Phrase: "Murphy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: P., Bulter, T., Kang, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bulter,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kang,"

Phrase: "D."
Processing 00000000.tx.332: E., Marquez-Sterling, N., Golde, T. 

Phrase: "E.,"

Phrase: "Marquez-Sterling,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.333: E., and Koo, E. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.334: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.335: (2001) Nature 414, 212-216[CrossRef][Medline] [OrderarticleviaInfotrieve] Geula, C., Wu, C., Saroff, D., Lorenzo, A., Yuan, M., and Yankner, B. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nature 414,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "212-216"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Geula,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Saroff,"

Phrase: "D."

Phrase: ","

Phrase: "Lorenzo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875453:LORENZO'S [Lipid,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Yuan,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.336: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.337: Med. 

Phrase: "Med."
Processing 00000000.tx.338: 4, 827-831[CrossRef][Medline] [OrderarticleviaInfotrieve] Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., and Seubert, P. 

Phrase: "4,"

Phrase: "827-831"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dunn,"

Phrase: "W.,"

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Grajeda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "J.,"

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Liao,"

Phrase: "Z.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mutter,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Soriano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shopp,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vasquez,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Vandevert,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "S."

Phrase: ","

Phrase: "Wogulis,"

Phrase: "M."

Phrase: ","

Phrase: "Yednock,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Seubert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.339: (1999) Nature 400, 173-177[CrossRef][Medline] [OrderarticleviaInfotrieve] Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 400,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "173-177"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bucciantini,"

Phrase: "M."

Phrase: ","

Phrase: "Giannoni,"

Phrase: "E.,"

Phrase: "Chiti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Baroni,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Formigli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Zurdo,"

Phrase: "J.,"

Phrase: "Taddei,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ramponi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dobson,"

Phrase: "C."
Processing 00000000.tx.340: M., and Stefani, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Stefani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: (2002) Nature 416, 507-511[CrossRef][Medline] [OrderarticleviaInfotrieve] Walsh, D. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nature 416,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "507-511"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Walsh,"

Phrase: "D."
Processing 00000000.tx.342: M., Klyubin, I., Fadeeva, J. 

Phrase: "M."

Phrase: ","

Phrase: "Klyubin,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fadeeva,"

Phrase: "J."
Processing 00000000.tx.343: V., Cullen, W. 

Phrase: "V., Cullen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1051267:Cullen [Plant]

Phrase: "W."
Processing 00000000.tx.344: K., Anwyl, R., Wolfe, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Anwyl,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.345: S., Rowan, M. 

Phrase: "S."

Phrase: ","

Phrase: "Rowan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330667:Rowan [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.346: J., and Selkoe, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.347: J. 

Phrase: "J."
Processing 00000000.tx.348: (2002) Nature 416, 535-539[CrossRef][Medline] [OrderarticleviaInfotrieve] Kuo, Y., Emmerling, M. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nature 416,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "535-539"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kuo,"

Phrase: "Y.,"

Phrase: "Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.349: R., Vigo-Pelfrey, C., Kasunic, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kasunic,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.350: C., Kirkpatrick, J. 

Phrase: "C., Kirkpatrick,"

Phrase: "J."
Processing 00000000.tx.351: B., Murdoch, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Murdoch,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.352: H., Ball, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.353: J., and Roher, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.354: E. 

Phrase: "E."
Processing 00000000.tx.355: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.356: Biol. 

Phrase: "Biol."
Processing 00000000.tx.357: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.358: 271, 4077-4081[Abstract/Free FullText] Franz, G., Beer, R., Kampfl, A., Engelhardt, K., Schmutzhard, E., Ulmer, H., and Deisenhammer, F. 

Phrase: "271,"

Phrase: "4077-4081"

Phrase: "[Abstract/Free FullText"

Phrase: "] Franz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004922:Beer [Food]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kampfl,"

Phrase: "A.,"

Phrase: "Engelhardt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Schmutzhard,"

Phrase: "E.,"

Phrase: "Ulmer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Deisenhammer,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.359: (2003) Neurology 60, 1457-1461[Abstract/Free FullText] Roher, A. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neurology 60,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1457-1461"

Phrase: "[Abstract/Free FullText"

Phrase: "] Roher,"

Phrase: "A."
Processing 00000000.tx.360: E., Lowenson, J. 

Phrase: "E.,"

Phrase: "Lowenson,"

Phrase: "J."
Processing 00000000.tx.361: D., Clarke, S., Woods, A. 

Phrase: "D."

Phrase: ","

Phrase: "Clarke,"

Phrase: "S."

Phrase: ","

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "A."
Processing 00000000.tx.362: S., Cotter, R. 

Phrase: "S."

Phrase: ","

Phrase: "Cotter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.363: J., Gowing, E., and Ball, M. 

Phrase: "J.,"

Phrase: "Gowing,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.364: J. 

Phrase: "J."
Processing 00000000.tx.365: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.366: Natl. 

Phrase: "Natl."
Processing 00000000.tx.367: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.368: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.369: U. 

Phrase: "U."
Processing 00000000.tx.370: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.371: A. 

Phrase: "A."
Processing 00000000.tx.372: 90, 10836-10840[Abstract/Free FullText] Selkoe, D. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "10836-10840"

Phrase: "[Abstract/Free FullText"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.373: J. 

Phrase: "J."
Processing 00000000.tx.374: (1991) Neuron 6, 487-498[CrossRef][Medline] [OrderarticleviaInfotrieve] Gravina, S. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuron 6,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "487-498"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gravina,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.375: A., Ho, L., Eckman, C. 

Phrase: "A.,"

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.376: B., Long, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Long,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.377: E., Otvos, L., Jr., Younkin, L. 

Phrase: "E.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Younkin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.378: H., Suzuki, N., and Younkin, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.380: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.381: Biol. 

Phrase: "Biol."
Processing 00000000.tx.382: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.383: 270, 7013-7016[Abstract/Free FullText] Jarrett, J. 

Phrase: "270,"

Phrase: "7013-7016"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jarrett,"

Phrase: "J."
Processing 00000000.tx.384: T., and Lansbury, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.385: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.386: (1993) Cell 73, 1055-1058[CrossRef][Medline] [OrderarticleviaInfotrieve] Harper, J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cell 73,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1055-1058"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Harper,"

Phrase: "J."
Processing 00000000.tx.387: D., and Lansbury, P. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.388: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.389: (1997) Annu. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.390: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.391: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.392: 66, 385-407[CrossRef][Medline] [OrderarticleviaInfotrieve] Bitan, G., Kirkitadze, M., Lomakin, A., Vollers, S., Benedek, G., and Teplow, D. 

Phrase: "66,"

Phrase: "385-407"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bitan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kirkitadze,"

Phrase: "M."

Phrase: ","

Phrase: "Lomakin,"

Phrase: "A.,"

Phrase: "Vollers,"

Phrase: "S."

Phrase: ","

Phrase: "Benedek,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.393: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.394: Natl. 

Phrase: "Natl."
Processing 00000000.tx.395: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.396: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.397: U. 

Phrase: "U."
Processing 00000000.tx.398: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.399: A. 

Phrase: "A."
Processing 00000000.tx.400: 100, 330-335[Abstract/Free FullText] Bitan, G., Vollers, S., and Teplow, D. 

Phrase: "100,"

Phrase: "330-335"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bitan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vollers,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.401: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.402: Biol. 

Phrase: "Biol."
Processing 00000000.tx.403: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.404: 278, 34882-34889[Abstract/Free FullText] Wurth, C., Guimard, N. 

Phrase: "278,"

Phrase: "34882-34889"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wurth,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Guimard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.405: K., and Hecht, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hecht,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.406: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.407: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.408: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.409: Biol. 

Phrase: "Biol."
Processing 00000000.tx.410: 319, 1279-1290[CrossRef][Medline] [OrderarticleviaInfotrieve] Deleted in proof Studier, F. 

Phrase: "319,"

Phrase: "1279-1290"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "Deleted in proof Studier,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0556981:% proof [Quantitative Concept]
   770   C1880274:Deleted [Activity]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.411: W., Rosenberg, A. 

Phrase: "W., Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979969:Rosenberg [Spatial Concept]

Phrase: "A."
Processing 00000000.tx.412: H., Dunn, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dunn,"

Phrase: "J."
Processing 00000000.tx.413: J., and Dubendorff, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Dubendorff,"

Phrase: "J."
Processing 00000000.tx.414: W. 

Phrase: "W."
Processing 00000000.tx.415: (1990) Methods Enzymol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.416: 185, 60-89[Medline] [OrderarticleviaInfotrieve] Kyte, K., and Doolittle, R. 

Phrase: "185,"

Phrase: "60-89"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kyte,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Doolittle,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.417: (1982) J. 

Phrase: "(1982"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.418: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.419: Biol. 

Phrase: "Biol."
Processing 00000000.tx.420: 157, 105-132[CrossRef][Medline] [OrderarticleviaInfotrieve] Minor, D., Jr., and Kim, P. 

Phrase: "157,"

Phrase: "105-132"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Minor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026193:Minor [Population Group]
  1000   C0205165:Minor [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Kim,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.421: (1994) Nature 367, 660-663[CrossRef][Medline] [OrderarticleviaInfotrieve] Chiti, F., Stefani, M., Taddei, N., Ramponi, G., and Dobson, C. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 367,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "660-663"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chiti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Stefani,"

Phrase: "M."

Phrase: ","

Phrase: "Taddei,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ramponi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Dobson,"

Phrase: "C."
Processing 00000000.tx.422: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.423: (2003) Nature 424, 805-808[CrossRef][Medline] [OrderarticleviaInfotrieve] Jao, S., Ma, K., Talafous, J., Orlando, R., and Zagorski, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nature 424,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "805-808"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jao,"

Phrase: "S."

Phrase: ","

Phrase: "Ma,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Talafous,"

Phrase: "J.,"

Phrase: "Orlando,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Zagorski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.424: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.425: (1997) Amyloid: Int. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.426: J. 

Phrase: "J."
Processing 00000000.tx.427: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.428: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.429: Investig. 

Phrase: "Investig."
Processing 00000000.tx.430: 4, 240-252 Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., and Shirasawa, T. 

Phrase: "4,"

Phrase: "240-252 Murakami,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Irie,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Morimoto,"

Phrase: "A.,"

Phrase: "Ohigashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shindo,"

Phrase: "M."

Phrase: ","

Phrase: "Nagao,"

Phrase: "M."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Shirasawa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.431: (2002) Biochem. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.432: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.433: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.434: Commun. 

Phrase: "Commun."
Processing 00000000.tx.435: 294, 5-10[CrossRef][Medline] [OrderarticleviaInfotrieve] Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. 

Phrase: "294,"

Phrase: "5-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Burdick,"

Phrase: "D."

Phrase: ","

Phrase: "Soreghan,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kwon,"

Phrase: "M."

Phrase: ","

Phrase: "Kosmoski,"

Phrase: "J.,"

Phrase: "Knauer,"

Phrase: "M."

Phrase: ","

Phrase: "Henschen,"

Phrase: "A.,"

Phrase: "Yates,"

Phrase: "J.,"

Phrase: "Cotman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.436: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.437: Biol. 

Phrase: "Biol."
Processing 00000000.tx.438: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.439: 267, 546-554[Abstract/Free FullText] Cubitt, A., Heim, R., Adams, S., Boyd, A., Gross, L., and Tsien, R. 

Phrase: "267,"

Phrase: "546-554"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cubitt,"

Phrase: "A.,"

Phrase: "Heim,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "S."

Phrase: ","

Phrase: "Boyd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347048:Boyd [Intellectual Product]

Phrase: "A.,"

Phrase: "Gross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439806:Gross [Qualitative Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Tsien,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.440: (1995) Trends Biochem. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.441: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.442: 20, 448-455[CrossRef][Medline] [OrderarticleviaInfotrieve] Waldo, G. 

Phrase: "20,"

Phrase: "448-455"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Waldo,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.443: S., Standish, B. 

Phrase: "S."

Phrase: ","

Phrase: "Standish,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.444: M., Berendzen, J., and Terwilliger, T. 

Phrase: "M."

Phrase: ","

Phrase: "Berendzen,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Terwilliger,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.445: C. 

Phrase: "C."
Processing 00000000.tx.446: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.447: Biotechnol. 

Phrase: "Biotechnol."
Processing 00000000.tx.448: 17, 691-695[CrossRef][Medline] [OrderarticleviaInfotrieve] Hecht, M., Das, A., Go, A., Bradley, L., and Wei, Y. 

Phrase: "17,"

Phrase: "691-695"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hecht,"

Phrase: "M."

Phrase: ","

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "A.,"

Phrase: "Bradley,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wei,"

Phrase: "Y."
Processing 00000000.tx.449: (2004) Protein Sci. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.450: 13, 1711-1723[Abstract/Free FullText] Serpell, L. 

Phrase: "13,"

Phrase: "1711-1723"

Phrase: "[Abstract/Free FullText"

Phrase: "] Serpell,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.451: C. 

Phrase: "C."
Processing 00000000.tx.452: (2000) Biochim. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.453: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.454: Acta 1502, 16-30[Medline] [OrderarticleviaInfotrieve] Makin, O. 

Phrase: "Acta 1502,"

Phrase: "16-30"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Makin,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.455: S., Atkins, E., Sikorski, P., Johansson, J., and Serpell, L. 

Phrase: "S."

Phrase: ","

Phrase: "Atkins,"

Phrase: "E.,"

Phrase: "Sikorski,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Johansson,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Serpell,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.456: C. 

Phrase: "C."
Processing 00000000.tx.457: (2005) Proc. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.458: Natl. 

Phrase: "Natl."
Processing 00000000.tx.459: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.460: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.461: U. 

Phrase: "U."
Processing 00000000.tx.462: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.463: A. 

Phrase: "A."
Processing 00000000.tx.464: 102, 315-320[Abstract/Free FullText] Johansson, J., Weaver, T. 

Phrase: "102,"

Phrase: "315-320"

Phrase: "[Abstract/Free FullText"

Phrase: "] Johansson,"

Phrase: "J.,"

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.465: E., and Tjernberg, L. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Tjernberg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.466: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.467: (2004) Cell. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.468: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.469: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.470: 61, 326-335[CrossRef][Medline] [OrderarticleviaInfotrieve] Pivi, A., Nordling, E., Kallberg, Y., Thyberg, J., and Johansson, J. 

Phrase: "61,"

Phrase: "326-335"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pivi,"

Phrase: "A.,"

Phrase: "Nordling,"

Phrase: "E.,"

Phrase: "Kallberg,"

Phrase: "Y.,"

Phrase: "Thyberg,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Johansson,"

Phrase: "J."
Processing 00000000.tx.471: (2004) Protein Sci. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.472: 13, 1251-1259[Abstract/Free FullText] Kallberg, Y., Gustafsson, M., Persson, B., Thyberg, J., and Johansson, J. 

Phrase: "13,"

Phrase: "1251-1259"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kallberg,"

Phrase: "Y.,"

Phrase: "Gustafsson,"

Phrase: "M."

Phrase: ","

Phrase: "Persson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Thyberg,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Johansson,"

Phrase: "J."
Processing 00000000.tx.473: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.474: Biol. 

Phrase: "Biol."
Processing 00000000.tx.475: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.476: 276, 12945-12950[Abstract/Free FullText] Pawar, A. 

Phrase: "276,"

Phrase: "12945-12950"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pawar,"

Phrase: "A."
Processing 00000000.tx.477: P., Dubay, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dubay,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.478: F., Zurdo, J., Chiti, F., Vendruscolo, M., and Dobson, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Zurdo,"

Phrase: "J.,"

Phrase: "Chiti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Vendruscolo,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Dobson,"

Phrase: "C."
Processing 00000000.tx.479: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.480: (2005) J. 

Phrase: "(2005"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.482: Biol. 

Phrase: "Biol."
Processing 00000000.tx.483: 350, 379-392[CrossRef][Medline] [OrderarticleviaInfotrieve] Creighton, T. 

Phrase: "350,"

Phrase: "379-392"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Creighton,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.484: (1992) Proteins, 2nd Ed., pp. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "2nd Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "pp."
Processing 00000000.tx.485: 171-200, W. 

Phrase: "171-200,"

Phrase: "W."
Processing 00000000.tx.486: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.487: Freeman & Co., New York Bonifacio, M., Sakaki, Y., and Saraiva, M. 

Phrase: "Freeman & Co.,"

Phrase: "New York Bonifacio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "M."

Phrase: ","

Phrase: "Sakaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1207167:sakaki [Plant]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saraiva,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.488: (1996) Biochim. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.489: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.490: Acta 1316, 35-42[Medline] [OrderarticleviaInfotrieve] LeVine, H., III (1993) Protein Sci. 

Phrase: "Acta 1316,"

Phrase: "35-42"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] LeVine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "(1993"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.491: 2, 404-410[Abstract/Free FullText] LeVine, H., III (1995) Amyloid: Int. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "404-410"

Phrase: "[Abstract/Free FullText"

Phrase: "] LeVine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "(1995"

Phrase: ")"

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.492: J. 

Phrase: "J."
Processing 00000000.tx.493: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.494: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.495: Investig. 

Phrase: "Investig."
Processing 00000000.tx.496: 2, 1-6 Naiki, H., Higuchi, K., Shimada, T., Takeda, T., and Nakakuki, K. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "1-6 Naiki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Higuchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shimada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takeda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Nakakuki,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.497: (1993) Lab. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.498: Investig. 

Phrase: "Investig."
Processing 00000000.tx.499: 68, 332-337[Medline] [OrderarticleviaInfotrieve] Jarrett, J., Berger, E., and Lansbury, P. 

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "332-337"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jarrett,"

Phrase: "J.,"

Phrase: "Berger,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.500: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.501: (1993) Biochemistry 32, 4693-4697[CrossRef][Medline] [OrderarticleviaInfotrieve] Petkova, A., Ishii, Y., Balbach, J., Antzutkin, O., Leapman, R., Delaglio, F., and Tycko, R. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochemistry 32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4693-4697"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Petkova,"

Phrase: "A.,"

Phrase: "Ishii,"

Phrase: "Y.,"

Phrase: "Balbach,"

Phrase: "J.,"

Phrase: "Antzutkin,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Leapman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Delaglio,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Tycko,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.502: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.503: Natl. 

Phrase: "Natl."
Processing 00000000.tx.504: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.505: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.506: U. 

Phrase: "U."
Processing 00000000.tx.507: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.508: A. 

Phrase: "A."
Processing 00000000.tx.509: 99, 16742-16747[Abstract/Free FullText]

Phrase: "99,"

Phrase: "16742-16747"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

